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Abstract 
Optimizing metabolic pathways is paramount for effective and economical production of 
biofuels and specialty chemicals. One such significant pathway is the cellobiose utilization 
pathway, identified as a promising route for efficient biomass utilization. Here we describe the 
simultaneous optimization of the β-glucosidase (gh1-1) and the cellodextrin transporter (cdt-1) 
through directed evolution of the pathway. The improved pathway was assessed based on 
specific growth rate on cellobiose, with the final mutant exhibiting a 42% increase over the wild-
type pathway. Metabolite analysis of the engineered pathway presented a 54% increase in 
cellobiose consumption (1.68 to 2.82 g cellobiose/(L·h)) and a 74% increase in ethanol 
productivity (0.59 to 1.03 g ethanol/(L·h)). By simultaneously engineering multiple proteins in 
the pathway, cellobiose utilization by S.cerevisiae was improved. This strategy can be generally 
applied to other metabolic pathways, provided a selection/screening method is available for the 
desired phenotype. This improved cellobiose utilization in vivo will not only decrease the in vitro 
enzyme load in biomass pretreatment, it will also reduce the diauxic shift in pentose sugar 
utilization, thus significantly reducing the high economics of biofuel processes. 
More than engineering microbes to more efficiently utilize the biomass sugars, constructing and 
designing pathways for biofuel production is also very significant.  We explored the 
development of a biodiesel production pathway using a heterologously expressed fatty acid 
synthase coupled with a wax ester synthase.  In this reaction, the esterification of a fatty acyl-
CoA and fatty alcohol catalyzed by the wax ester synthase produces free fatty acid ethyl esters, 
otherwise known as biodiesel.  Only initial experiments have been completed in this project, 
including initial enzyme characterization and plasmid construction. 
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Chapter 1: Sustainable Energy Production 
1.1 Sustainability 
Dwindling natural resources, including fresh water and petroleum, is causing industries and 
governments to reconsider design principles of industrial processes.  Sustainability has now 
become a major component of all sectors of industrial, governmental, and even societal agencies.   
Though the definition of sustainable development has been argued over the years, a standard 
definition has emerged as “.  .  .  a process of change in which the exploitation of resources, the 
direction of investments, the orientation of technological development, and institutional change 
are all in harmony and enhance both current and future potential to meet human needs and 
aspirations.  .  .  (It is) meeting the needs of the present without compromising the ability of 
future generations to meet their own needs” (1). 
 
1.1.1 Sustainable Development and the Energy Crisis 
Sustainable development has been cited as the most difficult challenge that humanity has ever 
faced (1).  To acquire sustainability, many fundamental issues at local, regional, and global 
levels must be addressed.  Industrial sustainability will require a global vision that holistically 
considers economic, social, and environmental sustainability, which considers more than just 
short-term profit margins, instead considering long-term investments (1).  Part of the challenge 
in sustainable development is that if a product is made sustainably, it must also be competitive 
with the conventional counterparts.  It must be cheaper, more durable, less toxic, and easily 
recyclable.  These products need to be derived from renewable resources and contribute 
minimally to net generation of greenhouse gases (1).  The technologies to produce those 
sustainable products competitively in the 21st century are only just emerging. 
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At the beginning of the 20th century, many commodity chemicals such as dyes, solvents, and 
synthetic fibers were made from renewable sources such as trees and agricultural crops.  By the 
late 1960s, many of these bio-based chemical products had been replaced by petroleum 
derivatives (2).  In recent decades, liquid petroleum consumption has increased dramatically for 
both commodity chemicals and energy.  Currently, $24 billion worth of hydrocarbon feedstock is 
used annually in the chemical industry (1). Though the chemical industry relies on petroleum, the 
most significant use of petroleum is for energy.  In 2011, a global consumption of 87.42 million 
barrels of petroleum each day (3).  Experts predict the energy demand to grow by more than 50% 
by 2025 (2). The company British Petroleum (BP) has mapped energy consumption since 1986 
and the trends energy demand increases at an alarming rate (Figure 1.1) (4).  In one single year, 
from 2010-2012, energy consumption grew by 2.5%, with China alone accounting for 71% of 
global energy consumption growth (4). 
Though the demand for energy is ever increasing, peak oil production is expected to be reached 
within the next fifty years (5-7).  Peak oil production describes the point in time when the 
maximum rate of petroleum extraction is reached, after that point, there will be a steady decrease 
in petroleum extraction.  Therefore, it is imperative to identify alternative resources for 
production of chemicals and energy which were previously petroleum based.  These are both 
incredible challenges, but this thesis focuses on the energy crisis.  
  
1.1.2 Alternative and Renewable Energies 
As petroleum resources are dwindling, alternative energies must be developed.  It is imperative 
that these alternative energies are derived from a renewable source; otherwise a second energy 
crisis could occur.  There are many avenues for renewable energies originating from natural 
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resources which can be replenished, such as sunlight, wind, rain, tides, biomass, and geothermal 
heat.  Currently about 16% of global energy consumption comes from renewables: 10% is 
produced from traditional biomass (mainly for heating), 3.4% from hydroelectricity, and the final 
3% is derived from new renewable technologies, such as biofuels, wind, and solar (8).   
To identify a strategy which will be most successful in identifying a renewable energy, the 
largest consumption of energy must be considered.  A breakdown of energy consumption with 
the United States yields the largest fraction of energy consumption to be hydroelectric power at 
40%, transportation fuels at 30%, industrial energy at 20%, and residential at 10% (Figure 1.2) 
(9).  When considering the largest amount of energy consumption, hydroelectric power is already 
derived from renewable sources, thus the next most significant energy consumption is 
transportation fuels.  These fuels are used for cars, planes, and trains.  Thus, to make the greatest 
impact on the energy crisis, major focus has been on attainment of renewable transportation 
fuels. 
There has been some success with electric cars (10), however the existing transportation fuel 
infrastructure relies on the burning of a carbon-based molecule.  Thus, the easiest renewable 
resource for transportation fuels would be biomass, producing a carbon-based molecule for 
combustion within an engine.  To this end, there has been some success with biofuels: in 2011 
the equivalent of  10,000 barrels per day oil was produced as biofuel (4). 
 
1.1.3 Biomass  
Biomass is a carbon-based as a renewable energy source derived from garbage, plant, and or 
waste.  Significant research for biofuels focuses on plant biomass.  Cellulose is the most 
abundant component of plant biomass, typically in the range of approximately 35 to 50% of plant 
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dry weight (11).  Cellulose is comprised of long polysaccharide chains of β-linked D-glucose 
molecules (12) (Figure 1.3).  The cellulose fibers are often embedded in a matrix of other 
structural biopolymers, primarily hemicelluloses and lignin, comprising of 20 to 35% and 5 to 
30% of plant dry weight, respectively (11).  The hemicellulose is a highly branched chain 
composed of cross-linked hexose sugars such as D-glucose and also the pentose sugars D-xylose 
and L-arabinose (12).  The lignin consists of phenols and chloroform alcohols which are 
generally considered unusable (Figure 1.4).   Degradation of these biopolymers are the dominant 
structural feature which limits the rate and extent of biomass utilization (11).   
 
1.1.4 Strategies for Biomass Conversion 
The conversion of biomass into usable fuels can be completed either through thermochemical 
routes, including gasification and pyrolysis, or through biochemical routes, such as 
microorganism fermentation.  Studies have shown that both processes are economically 
comparable for the production of biofuels (13). 
 
1.1.4.1 Thermochemical Routes 
One thermochemical process is gasification: a transformation of raw material into a gaseous 
mixture through a series of chemical reactions in a controlled amount of air and high temperature 
(14).  The gaseous product is an energy rich mixture of H2, CO, CO2, CH4, C2H4, and other 
impurities such as nitrogen, sulfur, alkali compounds, and tars (15).  Different gases or air used 
in the gasification chemical reaction can yield different products.  Specific gasification of the 
biomass can be used to convert the biomass into a hot synthesis gas, „syn-gas‟ (16).  Syn-gas can 
then be converted to a variety of fuels including hydrogen by a water gas-shift reaction, a 
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standard reaction where CO reacts with water to form CO2 and H2.  Methanol is also produced 
through methanol synthesis: after the water gas-shift reaction occurs, the CO reacts with water to 
form CO2 and H2, and then there is a hydrogenation of CO2 to methanol.  Alkanes are produced 
from the biomass by Fischer-Tropsch synthesis using Co-, Fe-, or Ru-based catalysts, the overall 
chemical reaction shown below (14) . 
CO + 2H2 →(1/n)CnHn + H2O 
Another thermochemical process, pyrolysis can produce solid, liquid, and gaseous products (17).  
Pyrolysis is differentiated from gasification because the reactions are completed in the absence 
of oxygen.  There has been significant success in chemical routes to produce transportation fuels 
from biomass (18).  Some of these successes include a pilot plant built by Honeywell for 
industrial scale biofuels, which is a 50 million gallon facility to produce green gasoline from 
biomass. 
 
1.1.4.2 Biochemical Routes 
Though thermochemical routes have shown to be successful, the processes require expensive 
catalysts and high temperature and pressures.  Thus, a more sustainable route is biochemical, i.e. 
microbial fermentation.  This process uses lower temperatures, atmospheric pressure, and near-
neutral pH.  Biotechnology had been declared a key technology for a sustainable chemical 
industry (1), thus it has been a focus as a technology for sustainable biofuels. 
 
1.1.4.2.1 Pretreatment 
In order for the microorganisms to ferment the biomass, it must first be broken down into the 
simple sugars that can be utilized.  This pretreatment step has been cited as one of the most 
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expensive processes for the biochemical conversion to biofuels (19).  The lignin must first be 
removed from the biomass mixture and the remaining components are treated through a variety 
of different methods.  The cellulose and hemicellulose can be broken down into individual 
sugars through either steam explosion, mechanical milling, high temperature treatment, and 
acid/base treatment to release individual sugar molecules (20).  These methods are energy 
intensive and use harsh solvents, thus if researchers are trying to make this process sustainable 
and economically competitive with petroleum products these are not good methods.  Thus, the 
preferred treatment is enzymatic hydrolysis.  An in vitro enzyme cocktail is used to digest the 
hemicellulose and cellulose molecules.  The cellulose molecule is broken down by cellulases, 
such as endoglucanases and cellobiohydrolases.  These enzymes cleave the long polysaccharide 
chain into disaccharide cellobiose molecules.  Subsequently, β-glucosidases hydrolyzes the β 
1→4 bond of the cellobiose, releasing two D-glucose molecules (21).  The hemicellulose fraction 
consisting of the linked pentose sugars are cleaved by hemicelluloses into singular molecules of 
D-xylose and L-arabinose (22).  The final hydrolysate contains a mixture of sugars: D-glucose, D-
xylose, and L-arabinose. 
 
1.1.4.2.2 Biochemical Conversion 
Biological processes are attractive because of the variety of specialty chemicals they can produce 
using a low-energy, low temperature, and low pressure system with non-toxic by-products.  The 
process does not require the use of heavy metals, organic solvents, and strong acids/bases often 
associated with traditional chemical synthesis, thus making the process sustainably  
environmentally-friendly (23).  Additionally, for many processes, and in the case of bioethanol 
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production, the system has been finely tuned by natural evolution for efficiency, thus 
biochemical routes for biofuel production hold significant promise. 
Different organisms have been used for biofuel production, including Saccharomyces cerevisiae, 
Escherichia coli, Zymomonas mobilis, and strains of Clostridium.  Both S.cerevisiae and E.coli 
are genetically tractable and desired for most work in microbial catalysis.  It is generally agreed 
that S.cerevisiae is the preferred chassis for biofuel production.  This microorganism is very 
industrially robust: tolerant to low pH, resistant to phages, and has a fast doubling time.  
Additionally, industrial-scale fermentation of this microorganism has been achieved through the 
beer/wine industry.  S.cerevisiae is most often used in current industrial-scale bioethanol 
production and is a goal for many future industrial processes.  However, most of the advanced 
biofuel studies are conducted in E.coli because this organism is easier to work with.  Future 
studies of advanced biofuel production will take part in yeast. 
  
1.2 Engineering Microorganisms 
The broad field of metabolic engineering has been established to engineer metabolic pathways 
within a microorganism to produce specialty chemicals.  As the field has evolved, a sub-field of 
pathway engineering has formed.  Pathway engineering focuses on optimizing the flux through 
the pathway itself, wherein metabolic engineering can also involve engineering of the host strain.  
The projects of this thesis focus on pathway engineering, as the studies have not yet included 
metabolic engineering strategies for host engineering.  Therefore, a detailed analysis of pathway 
engineering techniques is described, to give a complete background to the pathway engineering 
methods which were utilized to complete this thesis. 
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1.2.1 Design and Construction of Pathways 
1.2.1.1 Computational Programs for Design 
In pathway engineering, there are many challenges, the first being the design of the pathway.  
Identifying a pathway may require sorting through thousands of possible enzymes and reactions 
wherein all the parameters have different substrate preferences and kinetic features.   
Computational algorithms have proven vital in pathway design and have the ability to discover 
de novo pathways by combining enzymes from various sources to produce non-natural products.    
Several databases containing enzymes and enzymatic reactions have been developed: Kyoto 
Encyclopedia of Genes and Genomes (KEGG) (24), BRaunschwig ENzyme DAtabase 
(BRENDA) (25), MetaCyc (26), the University of Minnesota Biocatalysis/Biodegradation 
Database (UM-BBD) (27,28), Retro-Biosynthesis Tool (ReBiT) (29), and the Universal Protein 
Resource (Uniprot) (30).   With these databases, it is possible to identify a staggering number of 
different pathways for synthesis of the same target compound.   Thus a major challenge in 
computational design is to rank candidate pathways to predict which pathway will have the 
highest yield of the desired compound.   
 
1.2.1.2 Homologous DNA Recombination Techniques 
There are different tools available to construct these large pathways.  One set of tools relies on 
homologous DNA recombination.  Of these tools, the DNA assembler method is efficient 
because it is a one-step in vivo pathway construction method.  (31).   This tool has been directly 
applied to construct pathways up to 45.3 kb in length with high efficiency.  The isothermal 
Gibson Assembly method developed uses an in vitro recombination system to assemble 
overlapping DNA fragments (32,33).   An enzyme cocktail containing T5 exonuclease, Phusion 
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polymerase, and Taq DNA ligase executes overhang chew-back, gap-filling, and ligation all in 
one-step.   Gibson and coworkers  reported the construction of a 16.3 kb mouse mitochondrial 
genome from 600 overlapping 60-mers in vitro, demonstrating that this method is a successful 
approach for multiple-fragment, multiple-size assembly. 
 
1.2.1.3 Restriction Digestion and Ligation Techniques 
The BioBrick and BglBrick methods are used to construct a metabolic pathway in a step-by-step 
manner.  Restriction digestions and ligations are implemented with compatible sticky ends 
generated by a set of specific restriction enzymes.  These two approaches allow operon 
construction, serving as building blocks for pathway assembly.  However, the slow manipulation 
and the existence of a scar in key locations prevent its wide application in pathway construction.   
The Golden Gate assembly method has attracted a lot of attention, due to its one-pot, one-step 
technology which can assemble multiple DNA fragments in 5 minutes. Type IIS enzymes 
recognize asymmetric sequences and cleave outside of these recognition sites, resulting in 
overhangs enabling the assembly by ligation.  Thus DNA can be inserted into a cloning vector 
with Type IIS restriction sites; after ligation, the target construct can be established. 
 
1.2.2 Optimization of Pathways 
However, pathway engineering is more than just recruiting various enzymes and stringing them 
together (34).  In early heterologous gene expression studies, it was discovered that there was 
significant growth inhibition in cells over-expressing superfluous genes.  This inhibition was 
attributed to the competition of protein synthesis machinery for essential proteins required for 
cell growth versus the production of the over-expressed proteins, and the demand for nucleotides 
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in the replication of the DNA itself.  This became known as the metabolic burden and reduction 
of the metabolic burden has become essential in the pursuit to identify an optimal metabolic 
pathway (35-38).  More than minimizing the metabolic burden, often one or two enzymes in the 
pathway will not express well or have low activity.  This causes a bottleneck or a build-up of 
intermediates in the pathway, thereby reducing the overall titer.  The following are techniques 
which have been developed to optimize a pathway through optimal protein expression and 
through altered protein activity.   
 
1.2.2.1 Chromosomal Integration  
There are disadvantages to the traditional plasmid-based expression system.  Plasmid instability 
has shown to be a major problem.  Due to the metabolic burden on the plasmid-bearing 
organism, it has a selective disadvantage compared to a plasmid-free cell.  Without selection 
pressure, an entire culture could be dominated by the plasmid-free cell. Integration into the 
chromosome leads to long-term stability and circumvents the loss of productivity by allele 
segregation due to plasmid-use.  Tyo and coworkers   (39) developed a technique called chemical 
inducible chromosomal evolution (CiChE) to integrate the heterologous genes into the 
chromosome at multiple sites, with up to 40 consecutive copies. 
 
1.2.2.2 Codon Optimization  
The degeneracy of the genetic code is exploited systematically in different ways by different 
organisms (40,41).  Studies have shown that organisms have a bias toward preferred codons and 
if a gene from an organism with a certain codon bias is heterologously expressed in a host with a 
different codon bias, the translation of the recombinant protein will be suboptimal.   This can be 
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overcome by codon optimization, wherein the codon sequence of the target gene is altered to 
match that of the codon bias of the host.   Codon optimization is commercially available from 
DNA synthesis companies and has proven to increase protein expression in multiple studies (42-
45).   
 
1.2.2.3 Operons and Tuning Intergenic Regions 
Grouping the genes of interest for the pathway into a single polycistronic mRNA can be 
beneficial to optimize the enzyme expression.  This one-step gene expression allows for 
simplified induction processes and improved regulatory mechanisms.  However, the design of 
the basic operon can greatly affect expression.   
Smolke et al. (46) showed that altering the mRNA stability by engineering the intergenic regions 
would increase protein production and thus overall titer.   By introducing RNA hairpin turns into 
the 3‟ and 5‟ intergenic region of the gene of interest, the mRNA was less susceptible to mRNA 
degradation.  This idea of independently controlling gene expression within an operon was 
further explored by Pfleger et al. (47).  By creating a library of tunable intergenic regions 
(TIGRs), the expression of several genes within an operon was simultaneously tuned for optimal 
expression.  The TIGRs contained control elements that include mRNA secondary structures, 
RNase cleavage sites, and ribosomal binding site (RBS) sequestering sequences.  The library of 
mutated intergenic regions was constructed and applied to the mevalonate pathway.  The final 
mutant product concentration was increased sevenfold compared to the original wild-type 
pathway.    
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1.2.2.4 Promoter Strength 
Promoters can be mutagenized to achieve precise strength and regulation.  These promoters of 
varying strengths have been applied to exhibit a broad range of genetic control, which can be 
selected to construct an optimal metabolic pathway.  Alper et al.  (48) used a library of mutant 
promoters with varying strengths to regulate the expression of the dxs gene, which led to the 
improvement of the volumetric productivity of lycopene.  It was found that optimal gene 
expression did not involve the strongest promoter.  A more broadly applicable method was 
recently established by Du et al (49), which relies on the DNA assembler method to 
automatically combine multiple libraries of mutant promoters of different strengths in a multi-
gene pathway.  Through a rigorous screening and selection process, the optimal combinations of 
mutant promoters in the pathway were identified, and involved a balanced expression level.   
This technique is especially powerful because it involves multiple promoters in a multi-gene 
pathway, optimizing the expression of all genes simultaneously   
 
1.2.2.5 Protein Engineering 
Protein engineering can be used to modify pathways.  The previous strategies rely on balancing 
protein expression, but these strategies cannot overcome innate inefficiencies in enzymes 
themselves.  Thus, engineering the proteins in the pathway can sometimes be the only way to 
improve the flux through the pathway 
As one of the most powerful tools in protein engineering, directed evolution mimics the 
Darwinian evolutionary process in a test tube and involves iterative rounds of creating genetic 
diversity followed by selection or screening (50-52) (Fig. 1A).  The most common genetic 
diversity creation methods include error-prone PCR, DNA shuffling, chemical mutagenesis, use 
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of a mutator strain, and saturation mutagenesis.  To identify improved mutants from this genetic 
diversity, a myriad of screening/selection methods have been developed such as colorimetric 
assays, colony size-based growth assays, and fluorescence activated cell sorting (FACS).  A 
major advantage of directed evolution is that no prior knowledge of the enzyme structure or 
mechanism is required to improve enzymatic properties.  Another advantage is the ability to 
mutate the entire enzyme, thus identifying residues distant to the active site that can affect 
activity through allosteric interactions.  However, a major disadvantage of directed evolution is 
the impossibility of exploring all sequence diversity, even with the most powerful screening or 
selection method.  Additionally, it can be difficult and time consuming to develop a high 
throughput screening/selection method for a target enzyme property (Figure 1.5a). 
Rational design is a knowledge-driven process which uses a priori information about enzymes 
such as sequence or structure.  This knowledge is used to make specific, targeted amino acid 
mutations which are predicted to affect enzymatic properties vital for the efficiency of the 
desired reaction (Figure 1.5b).  This strategy can be valued more than directed evolution because 
it limits the onerous task of screening the large libraries from directed evolution.  In a sequence-
based knowledge approach, researchers pursue systematic comparisons of homologous protein 
sequences to identify possible residues that could alter protein activity.  When the three-
dimensional crystal structure of the target enzyme or a homologous enzyme is available, a more 
direct structure-function relationship study between residues can be investigated. Critical 
residues that are hypothesized to affect the desired function are targeted for mutagenesis.  By 
visualizing the active site, rational design can be used to mutate the large residues to smaller, 
hydrophobic residues, thus enlarging the active site and allowing a larger substrate to bind.  
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Various computational tools have been developed to compare the homologous sequences and 
structural databases to create a mutability map for a target protein (53-55) (Figure 1.5b). 
Distinctions between rational design and directed evolution are becoming less clear, as 
researchers commonly combine these techniques (Figure 1.5c).  Though strategies to conjoin the 
methods vary, one strategy involves a two-step process of directed evolution and then identifying 
hotspots for rational design, or vice versa if used in de novo protein design.  Another strategy to 
combine these techniques is semi-rational design.  The power of semi-rational design lies in the 
reduction of the library size to be screened and an augmentation of the success rate for 
identifying  positive hits (56).  Semi-rational design can target specific residues for saturation 
mutagenesis or target and mutagenize a specific domain that is suspected to have critical 
function.  These intelligent libraries rely on the ability to identify key beneficial mutations 
through critical structure-function relationships and knowledge of mutational effects on protein 
folding and activity.  This design process harnesses the power of the directed evolution but 
reduces the onerous screening.  Techniques to develop these smart libraries have been diverse 
and efficient (51,52).   
 
1.2.2.5.1 Engineering Enzyme Specificity or Selectivity 
Both rational design and directed evolution have successfully been used to engineer enzyme 
specificity or selectivity to improve a pathway performance.  Often, the promiscuity of enzymes 
tends to correlate with low catalytic activity and undesired side-reactions.  This yields an 
inefficient pathway with build-up of intermediates and by-products, which can be toxic to the 
cell.  By redesigning proteins for increased specificity or selectivity toward the desired substrate, 
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less substrate is required for a high titer and fewer by-products are formed.  This strategy has 
proven to be one of the most successful strategies to optimize a pathway through protein design.    
One particular example of reducing side-reactions of enzymes is the production of specialty 
chemical triacetic acid lactone (TAL) (57).  The fatty acid synthase (FAS) is a bifunctional 
enzyme, but was rationally designed through sequence homology and structure-function 
relationships to inactivate the keto reductase domain.  This eliminated the enzyme‟s ability to 
utilize NADPH, making one function inactive.  As a result, the carbon flux was shifted 
exclusively to the desired product TAL.  Another example did not completely eliminate 
secondary activity, but increased selectivity towards the desired reaction.  Nair and Zhao (58) 
engineered a xylose reductase with preferred selectivity for xylose over arabinose.  Screening the 
error-prone PCR library revealed mutations clustering around the (β/α)8-barrel, which led to 
speculation that this region was involved in substrate recognition.  Targeting this secondary 
structure, the site-saturation mutagenesis led to a final mutant with an increased selectivity from 
2.4- to 16.5- fold preference for D-xylose.   
Zhang and coworkers (59) engineered a promiscuous KivD for preferred substrate selectivity, 
which expanded E.coli metabolism to produce unnatural C5 to C8 alcohols, used for biofuels.  
The KivD specificity constant kcat/Km was engineered through rational design to 40-fold higher 
preference for 2-keto-4-methylhexanoate than its cognate substrate, 2-ketoisovalerate.  This was 
a 10-fold increase over the wild-type selectivity.  The α-keto acid binding pocket was enlarged 
by mutating proximal residues to smaller, hydrophobic amino acids, allowing binding of the 
larger substrate.  In this same report, LeuA was rationally designed for increased activity for the 
substrate of interest, 2-keto-3-methylhexanoate.  The crystal structure suggested that steric 
hindrance of the methyl group in the 2-keto-3-methylhexanoate could be relieved by mutating 
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proximal residues.  The mutation, S139G, was identified to increase the kcat 7-fold towards the 
substrate of interest.  The combination of the mutated KivD and LeuA produced several non-
natural alcohols, which were not produced in the wild-type pathway.   
Just as significant as the substrate, the cofactor NAD(P)+ and NAD(P)H usage can be engineered 
to increase the overall efficiency of the pathway.  Properly designed proteins can reduce the 
competition for the cofactors between cell metabolism and enzymes in the pathway.   An internal 
cofactor regeneration strategy was incorporated into the xylose utilization pathway to reduce the 
imbalance between the xylose reductase (XR) and xylitol dehydrogenase (XDH) for biofuel 
production.   In one study, the XDH enzyme was engineered for switched cofactor specificity to 
NADP+, which would complement the XR cofactor preference of NADPH (60,61), creating an 
internal cofactor regeneration mechanism.  In another study, the XR was altered to have a 
preference for NADH, to complement the XDH of NAD+, which led to a 40-fold increase in 
ethanol productivity over the wild-type enzyme (62).    
 
1.2.2.5.2 Improving Protein Activity 
Though improving the substrate/cofactor specificity or selectivity of enzymes can increase flux, 
there are many other ways to engineer enzymes to increase the overall performance of a 
pathway.  More active enzymes can increase the performance of pathways, and the higher 
enzymatic activity can be achieved by improving the catalytic efficiency, protein solubility, and 
stability.  Additionally, the pathway can be optimized by increasing the activity of the transport 
system transferring the extra-cellular substrates into the cell.   
Leonard and coworkers (63) engineered two enzymes from the diterpenoid biosynthetic pathway, 
geranylgeranyl disphosphate synthase (GGPPS) and levopimaradiene synthase (LPS) for 
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levopimaradiene production.  Saturation mutagenesis was applied to possible critical residues of 
the LPS while error-prone PCR was utilized to engineer the GGPPS.  The most improved 
GGPPS (S239C/G295D) and LPS (M593I/Y700F) were cloned into the full pathway and when 
combined with metabolic engineering strategies, resulted in a 2,600-fold increase in 
levopimaradiene production.  The mutations in the GGPPS were hypothesized to affect the 
GGPPS catalysis by improving the binding efficiency of the magnesium ions needed for 
substrate anchoring. 
Increasing the overall enzyme activity through traditional directed evolution was eloquently 
illustrated by Atsumi and Liao in a study focusing on 1-propanol and 1-butanol synthesis in E.  
coli (64).   A combination of error-prone PCR and DNA shuffling through six rounds of directed 
evolution identified a top candidate, called CimaA3.7.   The kcat/Km of CimaA3.7 for acetyl-CoA 
was 6.7 times greater than the wild-type enzyme at 30 ºC.   The enzyme activity was screened at 
varying temperatures and CimA3.7 showed higher activity than wild-type at all temperatures 
tested.  Once re-inserted into the pathway, this enzyme yielded a 9.2-fold improvement in 1-
propanol production and a 21.9-fold improvement in 1-butanol production. 
Transporters can be the greatest limiting factor in a pathway.  However, engineering these 
proteins has been an underutilized strategy for improving the performance of pathways.   Lack of 
three-dimensional crystal structure has limited the engineering of these proteins to error-prone 
and directed evolution.  Young and coworkers (65) engineered xylose transporters with an 
improved growth rate of up to 70% on xylose as the sole carbon source.  In this engineering 
effort, the transporters with increased affinity towards xylose were also discovered to have a 
lower Vmax.   
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1.2.3 Engineering Biochemical Pathways for Biofuels 
As previously mentioned, hexose (D-glucose) is a main constituent of biomass; however pentose 
sugars such as D-xylose and L-arabinose from the hemicellulose fraction can contribute to a large 
component of the biomass.  S.cerevisiae and E.coli cannot utilize these pentose sugars.  Thus, a 
significant amount of engineering has transpired to design these microorganisms to efficiently 
utilize these sugars to produce bio-ethanol.  Bio-ethanol has emerged as a first-generation 
biofuel.  However, it is well established that this biofuel is inefficient, with low heating 
properties and inefficiencies.  Thus, production of advanced biofuels has now become a focus: 
butanol, biodiesel, alkanes, and hydrocarbons.  Though many studies recently focused on 
producing advanced biofuels, either through E.coli or S.cerevisiae, no study has linked pentose 
utilization to advanced biofuel production. 
 
1.2.3.1 Pentose Sugar Utilization and Bioethanol Production 
Optimizing the pentose sugar utilization pathway has two main thrusts: engineering transporters 
to transport the sugars into the cell without incurring a diauxic shift and optimizing the enzymes 
which convert the sugars to ethanol. 
 
1.2.3.1.1 Engineering Transporters 
The diauxic shift describes a phenomenon wherein if a mixture of sugars is present, such as D-
glucose, D-xylose, and L-arabinose, the microorganisms will preferentially utilize the glucose 
molecules, subsequently the xylose and finally the arabinose.  This sequential sugar utilization 
greatly decreases overall efficiency of the process (12,66-68).  Many metabolic engineering 
techniques have been used to overcome this phenomenon.  Specifically, pathway engineering 
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strategies focus on engineering the transporters themselves.  It has been shown that using 
pentose-specific transporters can reduce the diauxic shift, because the sugars will not utilize the 
same transporters as the glucose molecules, allowing for simultaneous transport.  These projects 
identified pentose-specific transporters and/or engineered the transporters for higher activity 
(65,69).   
Another strategy for reducing the diauxic shift is to utilize cellobiose as a carbon source.  
Cellobiose is a glucose dimer and can be transported into the cell by a recently discovered 
cellodextrin transporter (70).  Previous work has reduced the diauxic shift by co-expression the 
cellodextrin transporter and a β-glucosidase with the xylose utilization genes (71,72). 
 
1.2.3.1.2 Xylose and Arabinose Utilization 
One of the most successful strategies for xylose utilization is the heterologous expression of the  
fungal xylose utilizing pathway. The xylose is reduced to xylitol by a xylose reductase (XR).  
Then the xylitol is oxidized to D-xylulose by a xylitol dehydrogenase (XDH).  Finally, a xylulose 
kinase (XKS) converts the D-xylulose to D-xylulose-5-P, which is then shuttled to the pentose 
phosphate pathway for ethanol production (Figure 1.6).  The arabinose pathway is similar: the 
arabinose is reduced to L-arabitol by the XR, an L-arabitol 4-dehydrogenase (LAD) reduces the 
arabitol to L-xylulose, which is then converted to D-xylulose by a L-xylulose reductase (LXR).  
Though the xylose pathway has shown to be efficient (49), this arabinose pathway is not. 
The imbalance of the cofactor usage between the enzymes is suspected to be the greatest limiting 
factor (73).  Strategies to over this limitation were previously discussed in the chapter, involving 
engineering enzymes for altered cofactor specificity.  Thus internal cofactor regeneration 
mechanisms were established.  Significant work has looked at balancing the promoters of the 
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xylose utilization enzymes.  These studies have shown that a high XR expression is important for 
an efficient pathway (49). 
 
1.2.3.2 Advanced Biofuels  
Though bioethanol has been marginally successful as a biofuels, more research is focusing on 
advanced biofuels, such as butanol, biodiesel, alkanes/alkenes, and hydrocarbons.  These 
advanced biofuels have more similar properties to petroleum-based fuels than ethanol, and are 
termed „drop in‟ fuels because they can readily be used by current engines in cars and planes. 
Recent work has focused on the Ehrlich pathway or the 2-keto-acid pathway for production of 
butanol and isobutanol.  Intermediates of the amino acid pathway, keto acids, are decarboxylated 
into aldehydes and then reduced to the products.  Isobutanol is perhaps one of the products 
produced by microbes which are closest to industrial use, with a high energy content and 
extensive branching, which gives it a higher octane number.  The octane number is a measure of 
a fuel‟s resistance to knocking in spark ignition engines (74).  The pathway was introduced into 
E.coli, the promiscuous decarboxylase and aldehyde dehydrogenase were engineered for 
increased substrate specificity in order for the final production of the non-natural carbon chains 
(59). 
Coupling microbial catalysis and chemical catalysis has been shown successful with isoprenoid 
based biofuels, such as farnesane (75) and bisabolane (76).  The intermediates farnesene and 
bisabolene are produced microbially and then chemically converted to farnesane and bisabolane, 
which are currently being investigated for as alternative biosynthetic diesel.  Plants are known to 
produce terpenes, thus, plant isoprenoid synthases were screened for efficient conversion of 
farnesyl diphosphate from the mevalonate pathway into bisabolene (76).   
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The cell membrane mainly consists of fatty acids.  Certain organisms often overproduce fatty 
acids which are used for energy storage.  The long hydrocarbon fatty acyl chain is energy rich, 
and can be used as a biofuel.  Fatty acids are biosynthesized naturally by either a large 
multienzyme system the fatty acid synthase or small sub-unit proteins.  The multienzyme system 
uses malonyl-CoA as a building block.  Fatty acyl chains are elongated on acyl carrier proteins 
(ACPs) through repeated cycles of decarboxylative condensation, β-keto reduction, dehydration 
and enol reduction (74).   
Thioesterases have been used to release the long-chain fatty acids to produce free fatty acid ethyl 
ester (FAEEs) (77).  Combined with the deletion of genes in the fatty-acid degradation pathway 
(β-oxidation), free fatty acids have been produced at high titers (1.2 g/L)  (78). 
 Alkane biosynthesis has recently been a major research focus.  Derived from fatty acids, alkanes 
are a predominant component of diesel.  Alkane biosynthetic genes were recently discovered in 
cyanobacteria (79).  The acyl-ACP reductase (AAR) was used to reduce the acyl-ACP to 
aldehydes which were then converted into alkanes by an aldehyde decarboxylase (ADC).  A 
combination of expression of these enzymes in E.coli produced alkanes from C13-C17 with final 
yield of 300 mg/L.  A figure summarizing some of the advanced biofuel pathways is available as 
Figure 1.7.  A more detailed discussion of advanced biofuels is available in Chapter 3. 
 
1.3 Overview of Projects 
The following projects in this thesis focus on the design, construction, and optimization of 
biochemical pathways for production of biofuels.  The second chapter entitled “Optimization of a 
Cellobiose Pathway through Directed Evolution” optimizes an already established cellobiose 
utilization pathway.  Though many of the techniques previously discussed to optimize the 
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pathway could have been used, in this project we developed a new strategy to engineer two 
enzymes simultaneously through directed evolution to increase the specific growth rate on 
cellobiose.  This is one of the few examples of directed evolution on the pathway scale.  Two 
rounds of genetic diversity identified a mutant pathway which increases the specific growth rate 
on cellobiose by 41% and increase ethanol productivity by 74%.  The enzymes were individually 
characterized to identify how the mutations affected the activity.  The β-glucosidase enzyme was 
engineered for increased substrate specificity and activity.  Simultaneously, the cellodextrin 
transporter was engineered for higher activity.  This project illustrates for the first time that 
multiple enzymes have been engineered in a single pathway simultaneously in S.cerevisiae. 
The third chapter involves the design and construction of a novel biochemical route for the 
production of free fatty acid ethyl esters (FAEEs).  The fatty acid synthase (FAS) from 
Brevibacterium ammoniagenes is used to heterologously produce excess fatty acid C16.  This 
enzyme is then coupled with a wax ester/ diacylglycerol acyltransferase (WS/DGAT) to produce 
the FAEEs.  Plasmid construction has been completed.  Initial single enzyme assays were 
completed for both the FAS and the WS/DGAT in S.cerevisiae.  The WS/DGAT was shown to 
be active, however, detection of C16 produced by the FAS was not detected.  Future work in this 
project will involve detection of FAEE and metabolic engineering to improve FAEE production. 
 
1.4 Conclusions 
Energy demand is increasing at an alarming rate, with an increase of 2.5% in 2011.  As peak oil 
extraction will be reached in the next 50 years, alternative energies must be identified.   One of 
the most efficient alternative energies is biofuels.  Engineering microorganisms to produce these 
biofuels is promising.  The techniques to optimize a metabolic pathway which produces these 
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biofuel-type molecules are wide and diverse.  Specifically, pathway engineering offers many 
different options to be able to optimize the flux through the pathway.  Though engineering the 
protein expression has proven successful, often there are limitations and inefficiencies of the 
enzymes which need to be engineered.  Thus, significant protein engineering tools and methods 
have developed.  This thesis focuses on developing a new method for the simultaneous 
engineering of multiple enzymes, which was applied to a cellobiose utilization pathway.  These 
same techniques can be applied to novel pathways for the production of advanced biofuels, but 
first those pathways must be designed and constructed.  In this thesis, a biodiesel pathway is 
designed and constructed.  Future work will optimize the constructed pathway. 
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1.6 Figures 
 
  
Figure 1.1: Energy consumption by region as predicted by BP in 2012 (4). 
 
Figure 1.2: Breakdown of energy resources and consumption in the United States in 2011.  Each 
number on the line indicates the percentage of that component (9). 
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Figure 1.3: A cellulose molecule. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Biomass composition (80). 
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Figure 1.5: Tools used for protein engineering. 
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Figure 1.6: Fungal heterologous pentose sugar utilization. 
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Figure 1.7: Pathways for different advanced biofuels (81). 
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Chapter 2: Optimization of a Cellobiose Utilization Pathway through Directed Evolution 
2.1 Background 
The saccharification of lignocellulosic biomass into fermentable sugars is recognized as one of 
the most expensive operations in biofuel process economics (1,2). Hydrolysis of the 
polysaccharide constituents of biomass into simple sugars requires an exorbitant amount of 
enzymes: endoglucanases (EC 3.2.1.4) and exoglucanases (EC3.2.1.74) that collectively break 
down the cellulose into cellobiose, a β-1,4-glucose disaccharide.  Finally, β-glucosidases (EC 
3.2.1.21) hydrolyze cellobiose to glucose which is subsequently fermented (3).  To reduce the 
requirement of these in vitro hydrolytic enzymes, recent research has investigated the option of 
utilizing cellobiose itself as a fermentable sugar.  Reducing the price of pretreatment will lower 
the cost of biofuel production, making biofuels more economically competitive with petroleum-
derived fuels (1,2).     
Three main strategies for heterologous cellobiose utilization have recently developed. The first 
strategy involves cell-surface display of extracellular β-glucosidases (4-7); the cell metabolizes 
two glucose molecules resulting from the extracellular hydrolysis of the cellobiose disaccharide.  
Another approach relies on heterologously expressed transporters and a cellobiose phosphorylase 
(8-10).  The cellobiose is transported into the cell and the phosphorylase cleaves the disaccharide 
with an inorganic phosphate, producing a glucose molecule and α-glucose-1-phosphate.  The 
final strategy relies on heterologous expression of a cellodextrin transporter and intracellular β-
glucosidase (11-13).  The intracellular cellobiose is hydrolyzed into two glucose molecules 
which are subsequently phosphorylated to glucose-6-phosphate (Figure 2.1).  Previous studies in 
our laboratory have investigated optimizing the hydrolytic cellobiose utilization pathway through 
combinatorial transcriptional engineering (14), however this optimization did not consider 
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protein activity.  Based on the promiscuity of the proteins involved in the hydrolytic pathway, we 
sought to apply protein engineering methods to improve the pathway.  
Current methods for protein engineering often involve isolating the protein from the context of 
the pathway and engineering it separately.  In this study, we have investigated a complementary 
strategy for protein engineering wherein we simultaneously modified multiple proteins in the 
context of the pathway (Figure 2.2).  Advantages of this strategy allow for simple and efficient 
library creation to identify pathways which can include mutations in each protein synergistically 
increasing the desired activity. This approach can be widely applicable to any pathway where a 
high-throughput screening/selection method for the desired phenotype is available.  The 
implementation of this directed evolution strategy will further enhance researcher‟s abilities to 
optimize pathways, introducing a next step in metabolic engineering involving pathway-driven 
approaches for protein engineering. 
Here we report the first example of simultaneously engineering multiple proteins, β-glucosidase 
(gh1-1) [GenBank Accession number XM_951090] and cellodextrin transporter (cdt-1) 
[GenBank Accession number XM_958708] in Saccharomyces cerevisiae for biofuel production.  
Through this directed evolution, key mutations were found in both of the proteins which 
synergistically improved the overall cellobiose utilization by 42%.  These mutations were 
directly linked to improved activity or altered substrate specificity of the proteins.  Though 
improving the cellobiose utilization for biofuel production is of interest, these results also 
augment recent research in β-glucosidase substrate specificity (15-18) and continued research in 
transporter engineering (10,19-22).  
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2.2 Results 
2.2.1 Library Construction and Screening 
The genes gh1-1 and cdt-1 were independently mutagenized through error-prone PCR and co-
assembled into the single copy pRS-KanMX plasmid under the PGK and TEF constitutive 
promoters, respectively.  The industrial S.cerevisiae strain Still Spirits (Classic) Turbo Distiller‟s 
Yeast purchased from Homebrew Heaven (Everett, WA).  This strain was used to assemble the 
pathway via the DNA Assembler method (23).  The genetic diversity for each gene was 2-3 
nucleotide mutations per kilobase in a library of over 104 mutants.  The growth rate on cellobiose 
as the sole carbon source was utilized as an assessment of pathway improvement, therefore 
screening was based on colony size from agar plates (14,24).  Large colonies from the library 
were visibly distinct from the wild-type parent pathway (Figure 2.3) and were selected for 
quantitative analysis.  Plasmids containing the mutant pathways exhibiting increased growth 
rates on cellobiose in oxygen limited conditions were retransformed into fresh yeast cells to 
confirm that the increased growth rate was caused by the mutated pathway and not from genome 
modification (Figure 2.4).  The first round of error-prone PCR yielded a mutant pathway (R1) 
which was used as template for the second round of error-prone PCR.  The second round of 
error-prone PCR resulted in the mutant pathway R2.  A third round of mutagenesis was 
performed but did not result in an improved phenotype. 
 
2.2.2 Characterization of the Mutant Cellobiose Utilizing Pathways 
The first mutant pathway, identified as (R1), resulted in the amino acid mutation L173H in the β-
glucosidase and a D433G mutation in the cellodextrin transporter.  The second round of 
mutagenesis (R2) resulted in a strain with additional mutations: H23L mutation in the β-
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glucosidase and a C82S mutation in the cellodextrin transporter.  R1 and R2 exhibited improved 
cellobiose growth, cellobiose utilization, and ethanol productivity compared to the wild-type 
cellobiose pathway in oxygen limited conditions (Figure 2.5).  There was a 42% increase in 
specific growth rate in the final mutant (0.075 h-1) compared to the wild-type (0.053 h-1). 
Metabolite analysis for the engineered pathways presented a 54% increase in cellobiose 
consumption and a 74% increase in ethanol productivity (Table 2.1).  Glucose production was 
minimal at less than 10 g/L and was found to be transient, being re-consumed quickly (Figure 
2.6).  The final mutant pathway, R2, consumed 80 g/L cellobiose in about 27 hours with an 
ethanol productivity of 1.03 g/(L·h) (Figure 2.5 and Table 2.1). 
The double and single mutations from each round were isolated and compared for specific 
growth rate and ethanol productivity (Figure 2.7) to determine which mutations had the most 
significant effect on the activity of the pathway.  Considering the mutation effects of each gene, 
the L173H mutation in the β-glucosidase is required in the pathway for a high growth rate.  In 
the cellodextrin transporter, the C82S mutation is also needed for higher growth rate and ethanol 
productivity. It is the combination of these mutations which confers a high growth rate. However, 
only when all four mutations are present, two from each protein, that the highest growth rate is 
achieved. 
 
2.2.3 Activity Assays 
2.2.3.1 β-glucosidase Assay 
The enzymes were assayed in vitro to better identify how the mutations affected the activity of 
the individual enzymes.  Initial tests on the β-glucosidase assayed the colorimetric reaction with 
p-nitrophenyl β-D-glucopyranoside (p-NPG), a common assay used for β-glucosidase activity 
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(15,17).  Compared to the wild-type, the L173H mutation conferred a reduction in hydrolytic 
activity towards p-NPG by 30%.  The combined L173H+H23L increased the activity slightly 
from the single L173H mutation.  Meanwhile, the single H23L mutation had similar activity to 
the wild-type on p-NPG.  Next, we assayed the activity towards cellobiose by enzymatically 
quantifying the glucose produced by a timed reaction of β-glucosidase with cellobiose.  Unlike 
the p-NPG assay, the L173H mutation increased the specific activity towards cellobiose by 90% 
compared to the wild-type.  The added H23L mutation conferred a 30% increase in cellobiose 
activity.  The isolated H23L mutation had only slightly higher activity than the wild type 
enzyme.  Overall, the β-glucosidase double mutant had 2.5-fold higher cellobiose hydrolytic 
activity than the wild-type enzyme, illustrating additive effects with the combined L173H and 
H23L (Table 2.2).  
 
2.2.3.2 Cellodextrin Assay 
The specific activity of the cellodextrin transporter was measured through a modified oil-stop 
assay based on the rate of radiolabeled sugar uptake (11,25).  The mutation D433G from R1 
conferred a small increase in cellodextrin transporter activity.  The combined mutations D433G 
and C82S increased the activity by 62%, while the single mutation C82S increased the transport 
rate by 46%.  This demonstrates that the C82S mutation is responsible for nearly all observed 
increase in the transport rate (Table 2.3).  
 
2.2.4 Structure/Sequence-Function Relationships 
A homology model was developed for the β-glucosidase and the mutations were investigated for 
structure-function relationships.  The homology model predicted that the L173H mutation was 
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located within the active site in the previously identified substrate entrance region (16).  The 
wild-type L173 did not have any predicted interactions with cellobiose.  While when the residue 
is switched to H173, it is predicted to have direct hydrogen-bonds to the hydroxyl group of the 
C1 atom (Figure 2.8).  The H23L mutation is on the periphery of the enzyme, far from the active 
site (Figure 2.9). 
No crystal structure is available for the cellodextrin transporter, therefore to visualize and 
hypothesize how these mutations affect the activity, a sequence-based analysis was performed 
with the aid of HMMTOP software (26,27).  This software is used to predict transmembrane 
helix domains, helix tail domains, and extra/intracellular loop structures (Figure 2.10).   Based on 
the predicted structure, the cellodextrin transporter is comprised of 12 transmembrane helices 
with one large inside loop and one large outside loop.  The D433G mutation is predicted to be 
located on the large outside loop and the C82S mutations is predicted to be in the first 
transmembrane helix. 
 
2.3 Discussion 
Efficient production of biofuels and specialty chemicals hinges on the optimization of the 
metabolic pathways associated with the product.  To this end, a variety of successful pathway 
optimization methods, mainly based on transcriptional engineering have been developed (14,28-
34).  Strategies in protein engineering are applied to overcome inefficiencies based on the innate 
characteristics and poor function of the enzymes themselves.  Often, these enzymes are removed 
from the pathway context and engineered in vitro or in vivo for the highest activity.  This task is 
arduously inefficient and there is no guarantee the engineered enzyme will reduce the bottleneck 
when it is reinserted into the pathway.  Protein engineering strategies can now be applied to 
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multiple enzymes on the pathway scale due to recent advances in large-scale library creation 
(14,24,35,36).  These library creation methods range from in vitro or in vivo assembly of 
plasmids or directly into the chromosome.  Our study illustrates in vivo library creation of 
plasmids for the simultaneous engineering of multiple proteins in a pathway through directed 
evolution in S.cerevisiae.  There has been only one example of the directed evolution of multiple 
proteins, which was illustrated in Escherichia coli for arsenate resistance (37).  Our work 
optimizes a sugar utilization pathway with increased metabolite products with a simple one-step 
assembly method, allowing for quick and efficient rounds of evolution, representing the first 
example of pathway optimization through multiple protein engineering for increased biofuel 
production in S.cerevisiae. 
The cellobiose utilization pathway offers different applications in biofuel production.  This 
pathway was originally investigated for co-utilization with xylose to reduce the diauxic shift or 
glucose repression during pentose sugar fermentations (11-13).  Perhaps more significantly, this 
cellobiose utilization pathway can reduce in vitro enzymes used in hydrolysis of the biomass.  In 
current processes, the  insufficient β-glucosidase activity results in an accumulation of cellobiose 
in the cellulose hydrolysate (38).  Thus engineering cellobiose utilization into S.cerevisiae for 
fermentation to biofuels is significant.  The hydrolytic and phosphorolytic pathways offer more 
efficient methods for utilization; however there is still an opportunity for optimization.  Recent 
studies adapted the phosphorolytic pathway for improved efficiency (10), including some work 
to engineer the cellodextrin transporter through adaptive evolution and alanine scanning.  The 
previous work in our laboratory optimized the hydrolytic pathway based on combinatorial 
transcriptional engineering, but we endeavored to engineer the proteins to improve the inherent 
characteristics of the enzymes.  
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The final optimized pathway (R2) increased the cellobiose consumption rate by 54% and ethanol 
productivity by 74%.  Glucose and cellodextrin accumulation in the supernatant, which was 
previously observed in the hydrolytic pathway (13,17), was also noted in the R2 pathway.  The 
accumulation occurred after all the cellobiose was utilized and was present only at 10 g/L.  
Application of this pathway for reduced in vitro enzyme pretreatment deems this by-product 
negligible.  Highest specific growth rates on cellobiose are observed only when the β-glucosidase 
L173H mutation is present.  The H23L mutation by itself did not lend a higher growth rate, even 
though it was coupled with the most active cellodextrin transporter.  In the cellodextrin 
transporter, the most significant mutation was clearly the C82S mutation, as this mutation 
conferred the highest specific growth rates.  However, both the β-glucosidase L173H and the 
cellodextrin transporter C82S mutations need to be present in order to achieve the highest growth 
rate.  This synergistic effect demonstrates the power of simultaneously engineering multiple 
proteins. 
The β-glucosidase, from glycoside hydrolase family 1 (GH1), contains the standard (α/β)-barrel 
structure of the enzyme family.  The active site is located in a deep cleft formed by the 
connection loops at the C-terminal end of the β-sheets of the TIM barrel (17) and negatively 
charged residues surround the bottom of the active site.  The conserved catalytic residues of the 
GH1 family involve the catalytic acid/base Glu 166 and the nucleophile Glu 377, which cleave 
the glycosidic bond via the common double displacement mechanism (15).  This mechanism acts 
on the β-1,4-linked glucose derivatives, thus the enzyme is promiscuous with a range of 
substrates with varied affinities (17).  The wild-type β-glucosidase enzyme has a 2.9-fold innate 
preference for p-NPG over cellobiose as a substrate. The directed evolution process performed in 
this study identified mutations in the enzyme that shift the specificity towards cellobiose.  The 
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L173H mutation is shown to be the most critical mutation for substrate specificity.  Homology 
modeling indicated the H173 residue can hydrogen-bond directly to the hydroxyl group of the C1 
atom (Figure 2.8).  In wild-type β-glucosidase, substrate docking is hypothesized to occur via an 
extensive network of polar interactions, where well-ordered water molecules and enzyme-
substrate hydrogen bonding keep the cellobiose firmly in place during hydrolysis (15,18).  
Recently, there has been significant interest in the β-glucosidase GH1 family focusing on 
substrate specificity (15-18).  This work has identified a residue that can further tailor the 
specificity of β-glucosidase towards cellobiose. 
The H23L mutation is considered to be an overall activity enhancer.  The single H23L mutation 
slightly improves overall enzyme activity towards both the p-NPG and cellobiose.  H23 is 
located on the periphery of the enzyme, quite distant from the active site (Figure 2.9).  It is 
probable that this mutation contributes to increased solubility or stability. As this amino acid 
residue was mutated from a hydrophilic to a hydrophobic side chain, it is possible the increased 
hydrophobicity allowed for more stable bonds between the peripheral residues. 
The screening method operated at saturating cellobiose concentration at 80 g/L.  As such, 
through this method the transporters were selected for increased Vmax, as the KM for the 
transporters were previously reported at 3 µM (11).  In the study, the mutants obtained did 
exhibit increased specific activity, associated with an increased Vmax of the transporter.  Though 
this is a biased screen, any industrial process for cellobiose utilization will likely occur at 
saturated cellobiose conditions, making it the most relevant condition to select at.  Recent studies 
in transporter engineering, which used a growth-based screen, also discovered mainly increases 
in Vmax (10,19) rather than improved KM.  The D433G mutation increased activity over the wild-
type by 10%. However, the combination of D433G+ C82S mutation increased the activity over 
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the wild-type by 62%.  It was shown that this increase in activity was attributed mainly to the 
C82S change as the single mutation also had a 46% increase in activity over the wild-type.  This 
was supported by the previous growth curve data wherein the highest growth rate occurred only 
when the C82S mutation was present. 
Modeling of transporter enzymes to identify the structure-function relationships is difficult due 
to the complexity of crystallizing membrane proteins.  Therefore, a prediction of the sequence- 
structure for the cellodextrin transporter was made using HMMTOP software (26,27). We can 
hypothesize and speculate how the mutations affected the phenotype by the location of the 
mutants on the predicted structure (Figure 2.10).  The D433G mutation is predicted to be located 
on a large outside loop. As this mutation results in the smallest possible non-charged residue, it 
can be speculated that the outside loop causes a steric hindrance for the mass transfer of 
cellobiose to the membrane, which can be alleviated by the altered loop structure with the 
smaller non-reactive residue.  The C82S mutation conferred the highest increase in activity and 
is predicted to be located in the first transmembrane helix. The location in the helix and the 
increased activity suggest that this mutation is directly associated with the protein complex 
stability or with the interaction with cellobiose.  A recent report on adaptive evolution and 
alanine screening of the cellodextrin transporter identified mutants with increase Vmax.  The 
mutant with the highest activity in that study is also predicted to be associated with a membrane 
helix, while the other less improved mutants are predicted to be on the loop structures (10).  A 
separate study in the directed evolution of xylose transporters identified mutations which tended 
to cluster around the first transmembrane helix (19), a similar finding to our study.  
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2.4 Conclusion 
Cellobiose utilization has recently become a significant consideration in economical biofuel 
production. Efficient utilization will not only decrease the in vitro enzyme load in biomass 
pretreatment but it will also reduce the diauxic shift in pentose sugar utilization. We successfully 
optimized the pathway by simultaneously engineering multiple proteins in the pathway.  This 
enabled the discovery of novel and synergistic mutations between the proteins, which conferred 
an improved phenotype of the entire pathway. 
 
2.5 Materials and Methods 
2.5.1 Strains, Media, and Culture Conditions 
The industrial Saccharomyces cerevisiae strain Still Spirits (Classic) Turbo Distiller‟s Yeast was 
purchased from Homebrew Heaven (Everett, WA). Yeast strains were cultivated in YP media 
(1% yeast extract, 2% peptone) with 2% glucose (YPD) or 2-8% cellobiose (YPC).  YPC with 
8% cellobiose was used in fermentation analysis while 2% cellobiose was used for plate 
screening.  S.cerevisiae strains were cultured at 30 °C with orbital shaking at 250 rpm for aerobic 
growth or 100 rpm for oxygen limited conditions.  As needed, 200 µg/mL G418 (KSE Scientific, 
Durham, NC) supplemented YPD for plasmid selection.  Escherichia coli DH5α (Cell Media 
Facility, University of Illinois at Urbana-Champaign, Urbana, IL) was used for recombinant 
DNA manipulations.  E.coli strains were cultured in Luria broth (LB) (Fischer Scientific, 
Pittsburgh, PA) at 37 °C and 250 rpm, supplemented with 50 µg/mL ampicillin.  Yeast and 
bacterial strains were stored in 15% glycerol at -80 °C.  All chemicals were purchased from 
Sigma Aldrich or Fisher Scientific. 
 
45 
 
2.5.2 Plasmid and Strain Construction 
Restriction enzymes were purchased from New England Biolabs (Ipswich, MA).    All cloning 
work was performed through yeast homologous recombination mediated by the DNA Assembler 
method (23).  Yeast plasmids were isolated using Zymoprep Yeast Plasmid miniprep II kit (Zymo 
Research, Irvine, CA), then transformed into E.coli for isolation of high purity DNA.  E.coli 
plasmids were isolated using Qiagen Spin Plasmid Mini-Prep Kit (Qiagen, Valencia, CA).  PCR 
fragments were purified by QIAQuick Gel Purification Kit (Qiagen, Valencia, CA). 
The β-glucosidase gene gh1-1 (GenBank Accession number XM_951090) from Neurospora 
crassa was expressed using a PYK promoter and an ADH terminator.  The cellobiose transporter 
gene cdt-1 (GenBank Accession number XM_958708) from N. crassa was expressed using a 
TEF promoter and a PGK terminator as previously constructed (13).  To transfer the pathway to 
the pRS-KanMX plasmid, primers kanMX-PYKp-F and PGKt-kanMX-R (Table 2.4) were used 
to amplify the full cellobiose utilizing pathway.  To facilitate the creation of a library of 
cellobiose utilizing pathways, a helper plasmid was constructed.  The helper plasmid contained 
the PYK promoter and the PGK terminator, separated by a unique restriction enzyme recognition 
site BamHI for plasmid linearization.  The helper plasmid will later be linearized and used as a 
backbone for the library creation.  The PYK promoter was amplified using primers kanMX-
PYKp-F and PYKp-BamHI-PGKt-R (Table 2.4).  The PGK terminator was amplified using 
primers PYKp-BamHI-PGKt-F and PGKt-kanMX-R (Table 2.4). 
 
2.5.3 Library Creation 
The ADH terminator and TEF promoter were not subjected to random mutagenesis, thus this 
cassette was amplified using primers middle-BGL-ADHt-F and middle-TEFp-CDT-R (Table 
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2.4).  This fragment was transformed with the error-prone PCR fragments and linear helper 
plasmid.  The gh1-1 and cdt-1 genes were subjected to error prone PCR and error rates of 2-3 bp 
mutations per 1kb were used for library creation.  The library was created according to the 
previously described method (14,24).  The total library size obtained was 104.  Ten colonies were 
randomly selected from the YPD+G418 plate and their plasmids were isolated and sequenced to 
confirm the diversity of the library. 
 
2.5.4 Library Screening 
The library was screened on YPC plates for large colony selection (14,24).  After confirmation 
of the top 5 clones with the fastest growth rate, the plasmids were isolated and retransformed.  
This retransformation ensured that no adaptation occurred in the screening process and the 
increased activity is from mutations on the plasmid.  After retransformation, the cells were 
seeded overnight in YPD+G418, washed twice with sterile water, and then inoculated into 50 mL 
YPC in 250 mL flask at 100 rpm and 30 °C (Figure 2.4). The cultures were sampled and 
analyzed for growth and also for metabolite production as described previously (14,24). After 
confirmation of improved mutant pathways, the plasmids were isolated and sequenced to identify 
the mutations within the genes in the pathway.  After confirmation of the mutations, that pathway 
was used as a template for a second round of error-prone PCR.  The library creation and 
screening process was repeated. 
 
2.5.5 Fermentation Analysis 
Seed cultures were inoculated from freshly streaked frozen stocks.  YPD+G418 seed cultures 
were used for the single/double mutant fermentation tests.  YPC seed cultures were used for final 
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mutant pathway analysis.  The seed cultures were grown at 30 °C and 250 rpm overnight, then 
washed with sterile water twice before inoculating 50 mL YPC in 250 mL un-baffled flasks to an 
initial OD of 0.2.  The cultures were incubated at 30 °C and 100 rpm for oxygen limited growth.  
The cultures were sampled and analyzed for growth and metabolite production. 
 
2.5.6 Construction of Single Mutants  
The single mutant genes were constructed through site-directed mutagenesis and the mega 
primer PCR method with primers listed in Table 2.4.  After PCR amplification, the genes were 
transformed into the Classic strain along with the ADHt/TEFp cassette into a linearized pRS-
KanMx helper plasmid.  The final plasmid was purified and sequenced for confirmation.   
 
2.5.7 β-Glucosidase Enzyme Activity Assays 
Classic strains harboring an empty vector, the wild-type, and mutant pathways were grown to 
mid-exponential phase and washed three times with potassium phosphate buffer (pH 7).  A final 
cell mass equivalent to an OD of 20 was harvested.  Cell free extracts were prepared through 
YPER Extraction Reagent (Thermo Scientific, Rockport, IL).  125 µL of YPER was used to lyse 
the cells for 20 minutes at 25 °C, vigorously shaken at 700 rpm in a thermomixer (Eppendorf, 
Germany).  After lysing, the cell membrane was pelleted for 10 minutes with 15,000 rpm at 4 °C.  
The protein concentration was determined via the BCA protein assay kit (Pierce, Rockford IL), 
following the standard manufacturer protocol. 
The lysate was tested for p-NPG activity by 1 mM p-NPG in 100 mM potassium phosphate 
buffer at pH 7.  The colorimetric change was monitored at 405 nm in a 96-well Biotech Synergy 
2 plate-reader (Winooski, VT) for 30 minutes at 30°C.  The change in absorbance was converted 
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to units (1 U = 1 µmol of p-NP/min) using Beer-Lambert law.  The extinction coefficient was 
determined by a standard curve using p-NP at pH 7.  For cellobiose-based enzymatic assay, the 
linear range of the β-glucosidase was determined. The reactions were carried out at 60 mM 
cellobiose in 100 mM potassium phosphate buffer at pH 7.  After addition of lysate, the reaction 
was allowed to react for 15, 30, 45, and 60 minutes at 30 °C.  The reaction was stopped by 
boiling at 100 °C for 10 minutes.  The samples were then centrifuged at 15,000 rpm for 5 
minutes before being stored on ice.  The amount of glucose which had been produced in the 
allotted time frame was then measured using the D-glucose kit (R-Biopharm, Germany).  
Standard manufacturer‟s instructions were followed.  One unit (U) is defined as micromoles of 
glucose produced per minute.  The specific activity was determined by normalizing the rate to 
the amount of protein in the assay.  
 
2.5.8 CDT Activity Assay 
The cellodextrin transporter was assayed using the oil-stop protocol previously reported (11,25) 
with few modifications.  Cultures of the wild-type and mutant pathways were grown to an OD of 
15-20, washed three times with ice-cold assay buffer (30 mM MES-NaOH + 50 mM ethanol), 
and then normalized to an OD of 20. 50 μL of cells were added to 50 μL of [3H]-cellobiose at 30 
°C and layered over 100 μL of silicone oil (Sigma 85419), incubated for 10, 20, 40, and 80 
seconds.  The cells were then centrifuged through the oil at 15,000 rpm for 30 seconds.  After 
ethanol/dry-ice bath, the cell pellets were solubilized in NaOH overnight.  The amount of [3H]-
cellobiose present in the cells was then quantified via a liquid scintillation counter.  The amount 
of labeled cellobiose that was taken up by the cell was plotted against the time of reaction.  One 
unit (U) is defined as the micromoles of cellobiose taken up by the cell per min.  The dry cell 
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weight of the cells was determined and the rate of the cellobiose uptake was normalized by the 
gram cell cry weight (gdcw).  
 
2.5.9 Homology Modeling 
A homology model of the β-glucosidase enzyme was constructed to identify the structure-
function relationships of the mutations discovered.  The gene encoding the β-glucosidase from 
Trichoderma reesei (17) (PDB accession code 3AHY) afforded the highest homology to the gh1-
1 gene from N. crassa with 73% sequence identity and was used as a template for homology 
modeling.  The structure model of the β-glucosidase from N. crassa was constructed using the 
modeling program Molecular Operating Environment (Chemical Computing Group, Montreal, 
Canada).  After constructing the homology model, the substrate in the co-crystal structure of 
Neotermes koshunensis β-glucosidase (PDB accession code 3VIK) was docked into the model 
(16).  The model was energy minimized before ligand interactions were investigated.  To identify 
the effects of the mutations, the mutations were introduced to the model and energy minimized 
again before investigating the ligand interactions.  
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2.7 Tables 
 
Table 2.1: Parameters for the improved pathways identified through directed evolution. Key 
parameters for an improved pathway include specific growth rate, cellobiose consumption, and 
ethanol productivity. Errors are derived from biological duplicates. Fermentations conditions in 
8% cellobiose rich media and oxygen limited conditions. 
 
 
 
 
Table 1: 
 
 
 
  
 
Wild-type R1 R2 
Specific Growth Rate     
  (h-1 ) 0.053 ±  0.002 0.063 ± 0.0003 0.075 ± 0.0002 
 
Cellobiose consumption     
      (g cellobiose/(L·h)) 1.68 ± 0.09 2.35 ± 0.07 2.815 ± 0.15 
 
Ethanol productivity         
      (g ethanol/(L·h)) 0.59 ± 0.02 0.674 ±0.03 1.03 ± 0.03 
 
Yield                               
    (g ethanol/g cellobiose) 0.418 ± 0.002 0.437 ± 0.002 0.447 ± 0.004 
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Table 2.2: Specific activity measurements from crude lysate of the engineered β-glucosidase 
isolated directly from the measured strain. One unit is defined as a µmol/min. Each mutant was 
quantified with p-NPG and cellobiose as a substrate to demonstrate the increased substrate 
specificity towards cellobiose. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
p-NGP  
(U/mg protein) 
Cellobiose 
 (U/mg protein) 
Empty Vector 0.0072 ± 0.0001 ND* 
Wild-type 0.194  ± 0.011 0.066 ± 0.0002 
L173H 0.133  ± 0.177 0.123 ± 0.003 
L173H + 
H23L 0.156 ±  0.009 0.163 ± 0.006 
H23L 0.219 ± 0.006 0.078 ± 0.003 
 
ND* = not detected 
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Table 2.3:  Specific activity measurements from the cellodextrin transporter as determined 
through radioactive-labeled cellobiose uprate assay. One unit is defined as 1 µmol/min.  
 
  
 
 
 
 
 
 
 
 
 
 
 
Table 2.4: Primers used in this study 
 
 
 
 
 
 
PGKt-kanMX-R 5‟-CCTCACTAAAGGGAACAAAAGCTGGAGCTCCACCGCGGTGGCAGGAAGAATACACTATAC-3‟ 
BGL EP-F 5‟-CTCTCTTGTTTCTATTTACAAGACACCAATCAAAACAAATAAAACATCATCACAATG-3‟ 
BGL EP-R 5‟-GCCGACAACCTTGATTGGAGACTTGACCAAACCTCTGGCGAAGAAGTCCAAAGCTTTA-3‟ 
CDT EP- F 5‟-CTTCTTGCTCATTAGAAAGAAAGCATAGCAATCTAATCTAAGTTTTAATTACAAAATG-3‟ 
CDT EP-R 5‟-GGATGGGGAAAGAGAAAAGAAAAAAATTGATCTATCGATTTCAATTCAATTCAATCTA-3‟ 
middle-BGL-ADHt-F 5‟-GAAGCCGCTCTTTGACTCTTTGATCAAGAAGGACTAAAGCTTTGGACTTCTTCGCCAGAG-3‟ 
middle-TEFp-CDT-R 5‟-CGGTGCTGGCCCCGTCATGGGAGCCGTGAGACGACATTTTGTAATTAAAACTTAGATTAG-3‟ 
B2-H23L-F 5‟-GGGTGCTATCCTCGCCGACGGCCGTGGC-3‟ 
B2-H23L-R 5‟-GCCACGGCCGTCGGCGAGGATAGCACCC-3‟ 
C2-C82S-F 5‟-CGCCTTTTGTAGTGCATGCGCCAACGG-3‟ 
C2-C82S-F 5‟-CCGTTGGCGCATGCACTACAAAAGGCG-3‟ 
qPCR-BGL-F 5‟-AACCAGAAGGGCATCGACCACTAT-3‟ 
qPCR-BGL-R 5‟-GCACTTGGGAATGGCCTTGAACAT-3‟ 
qPCR-CDT-F 5‟-AATCCCCTCGCTTCCTATTTG-3‟ 
qPCR-CDT-R 5‟-TCCTGATACCGTCCCTCATC-3‟ 
CDT sequencing-TEPp-F 5‟-CTTTCGATGACCTCCCATTGATATTTAAG-3‟ 
CDT sequencing- PGKt-R 5‟-CGAATGGGAAAAAAAAACTGCATAAAGGC-3‟ 
BGL sequencing-F 5‟-CCTTTGGTTTTTTATTCTTAACTTG-3‟ 
BGL sequencing- R 5‟-GAAGTGTCAACAACGTATCTACCAACG-3‟ 
 
 
Cellobiose Uptake 
Rate  
(U/gcdw) 
Empty Vector 0.006 ± 0.000 
Wild-type 1.760 ± 0.109 
D433G 2.084 ± 0.134 
D433G+C82S 2.849 ± 0.358 
C82S 2.565 ± 0.093 
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2.8 Figures 
  
 
Figure 2.1:  The hydrolytic cellobiose utilization pathway used in this study. 
 
 
 
 
 
 
Ethanol
β-glucosidase
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Figure 2.2: A general scheme for the directed evolution of multiple proteins within a metabolic 
pathway. Diversity is introduced to the genes through error-prone PCR, DNA shuffling, or other 
mutagenesis techniques. The genes are then recombined through homologous recombination into 
the pathway. A non-mutagenized fragment for the interior - promoter and terminator is also 
amplified and assembled. Screening is accomplished via colony size on cellobiose agarose 
plates. Large colonies are associated with faster growth and selected for further analysis. To 
confirm phenotype is a result of the improved pathway and not from adaption, the pathways are 
retransformed. Improved mutants are selected for a second round of diversification and 
screening. 
Parent as template
KanMX
gh1-1
cdt-1
Retransform
Screen on 
cellobiose  plates
Most active 
used as 
template 
7
Ethanol Production                  Growth
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             (a)      (b) 
Figure 2.3: Selection plates of the error-prone library on cellobiose plates, depicting the large 
colonies. (a) wild-type pathway with all uniform colonies (b) error-prone PCR library. 
 
         
 
Figure 2.4: (a) Specific growth rates of mutants in the top 10% fastest growers in the initial tube 
screening of the library created by the first round of error-prone PCR. (♦) is the wild-type 
pathway (♦) depicts the selected clones, numbered on the x-axis.  (b) Cellobiose utilization from 
confirmation of clones with high specific growth rate fermentation carried out in oxygen limited 
conditions in un-baffled flasks.  (■) (♦) denote the wild-type pathway cellobiose consumption, 
(■) (x) represent two of the faster cellobiose utilizing pathways. 
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 (a)  
 
(b)  
(c)  
 
Figure 2.5: Fermentation profile of the cellobiose utilization pathways under oxygen limited 
conditions: (■) wild-type pathway, (●) R1 pathway, (▲) R2 pathway (a) Growth curve, (b) 
Cellobiose utilization, (c) Ethanol production. Error bars derived from biological duplicates. 
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Figure 2.6: Glucose accumulation in oxygen limited fermentation (■) wild-type pathway, (●) R1 
pathway, (▲) R2 pathway. 
 
 
 
 
 
 
 
 
 
 
 
 
 
61 
 
 (a)     
(b)  
Figure 2.7:  (a) Growth rate and (b) ethanol productivity of the single and double mutants on 
cellobiose as a sole carbon source. Error bars are derived from biological duplicates. Each bar 
represents the mutation in the β-glucosidase coupled with that of the cellodextrin transporter. The 
black bar is the wild-type, the red bar is the L173H, the blue bar represents the double mutant 
L173H and H23L, and the final grey bar is the single H23L. * denote statistically significant 
values over the wild-type (p < 0.05).  Error bars are currently being completed for (b). 
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(a)  
 
 
 
(b)  
 
Figure 2.8:  Homology model of the N. crassa β-glucosidase with the cellobiose substrate 
docked into the active site. (a) The critical residue in the wild-type enzyme L173 has no 
predicted interaction with the cellobiose molecule. (b) The mutated residue H173 is predicted to 
have direct hydrogen bonding with the hydroxyl group on the C1 atom of the cellobiose 
molecule.  
63 
 
 
 
Figure 2.9:  Homology model of the N. crassa β-glucosidase with the cellobiose substrate 
docked into the active site. The L23 mutation is notably far from the active site and the 
cellobiose substrate down in the center. 
 
 
Figure 2.10: Sequence-structure based mapping of the cellodextrin mutations. The HMMTOP 
software predicted sequence-structure of the transmembrane helix, inner, and outer loops of the 
cellodextrin transporter in the cell membrane. The top of the graphic depicts outside of the cell, 
while the bottom. The mutations were overlaid onto the structure prediction. 
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Chapter 3: Engineering a Novel Pathway for FAEE Biosynthesis 
3.1 Background 
Industrial-scale bioethanol production through yeast has been marginally successful; however it 
is not a preferred biofuel molecule.  Bioethanol has low energy intensity, high vapor pressure 
and is corrosive to engines.  Thus, there is a great interest in microbial production of advanced 
biofuels such as butanol, propanol, alkane, alkenes, and biodiesel.   
Biodiesel is a particularly interesting fuel molecule, as it can be easily derived from fatty acids.  
Fatty acids are only one catalytic step away from petroleum-derived diesel molecules and thus 
have become a focus in advanced biofuel production.  Fatty acid ethyl esters (FAEEs), another 
name for biodiesel, are a non-toxic and completely biodegradable fuel.  Compared to gasoline, 
using FAEEs can reduce emissions due to less carbon monoxide, sulfur, aromatic hydrocarbons 
and soot particles produced from the combustion process (1).  FAEEs were previously produced 
via a transesterification reaction from plant or animal oils with ethanol.  This process is energy 
intensive and expensive, thus recent microbial engineering efforts have focused on producing 
FAEEs.  Figure 3.1 shows a simplified general scheme for the microbial production of FAEEs. 
 
3.1.2 Fatty Acid Synthesis 
FAEEs can be produced microbially from fatty acids.  Therefore, maximum production of fatty 
acids has become a focus in recent research projects.  Though there are many different platforms 
and systems to produce fatty acids in different organisms, the overall catalytic mechanisms are 
the same.  The first committed step in fatty acid biosynthesis is the carboxylation of acetyl-CoA 
by acetyl-CoA carboxylase (ACC).  This forms malonyl-CoA, which is subsequently converted 
by malonyl CoA:ACP transacylase (FabD) to malonyl-ACP.  A series of iterative chain 
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elongation steps then occur in a cyclical fashion.  The growing acyl chain is covalently attached 
to the acyl-carrier protein (ACP) through a thioester linkage on the terminal sulfhydryl of the 
phosphopantetheine prosthetic group.  The first elongation step is initiated by the Claisen 
condensation of malonyl-ACP with an acyl-CoA, catalyzed by the first condensing enzyme β-
ketoacyl-ACP synthase III (FabH).  This forms β-ketoacyl-ACP.  The FabR-FabB proteins (3-
ketoacyl-ACP synthases) condense malonyl-ACP with acyl-ACP to extend the acyl chain by two 
carbons.  This is the only irreversible step in the elongation cycle.  The NADPH-dependent β-
ketoacyl-ACP reductase FabG reduces the β-keto group to a β-hydroxy intermediate.  This 
intermediate is then dehydrated by the β-hydroxyacyl-ACP dehydratase known as FabZ or FabA 
to a trans-2-enoyl-ACP.  The final step reduces the enoyl chain by the NADPH-dependent FabI, 
FabL, or NADH dependent FadV enoyl-ACP reductase.  After each complete cycle of 
condensation and chain reduction, the growing acyl chain is transferred back to the ketosynthase 
to initiate the next cycle (2) (Figure 3.2). 
These reactions are catalyzed by two classes of enzymes which are divided by their architecture.  
Type II fatty acids are comprised of distinct individualized enzymes which independently 
complete the condensations and reductions.  These systems are generally found in bacteria and 
other prokaryotes.  Eukaryotes generally have a Type I fatty acid synthase (FAS) (Figure 3.3), 
which is a large globular enzyme.  The microbial FAS enzyme is a hexamer protein with the 
domain arrangement of acyltransferase (AC), enoyl reductase (ER), dehydratase (DH), 
malonyl/palmitoyl transferase (MPT), acyl carrier protein (ACP), 3-ketoacyl reductase (KR), and 
3-ketoacyl synthase (KS).  The FAS of yeast and mycobacteria use an integral MPT activity for 
transacylation of the acyl-enzyme product.  The fatty acid biosynthesis is initiated by the FAS 
component enzyme acetyltransferase, loading the acyl primer, usually acetate, from coenzyme A 
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(CoA) to a specific binding site on the FAS (3).  Termination occurs by removing the product 
from FAS either by transesterification to an appropriate acceptor, usually palmitoyl transferase 
or a thioesterase. The iterative chain elongation mechanism involves enzyme bound 
intermediates being cycled through the catalytic domains.  The chain length of the product is an 
inherent characteristic of each individual FAS (3).  Bacterial type I fatty acid synthases have 
shown to be different from other FASs by being primarily bimodal in the chain length products, 
generally producing a chain length of 16 to 18 and also 24 to 30 carbons.  Bacterial type I fatty 
acid synthases also differ from yeast FASs by utilizing the cofactors NADPH and NADH (3).  
Additionally, the bacterial apoFAS activating phosphopantetheine transferase is encoded by a 
separate gene, rather than being integrated into the large FAS, which occurs in yeast. 
This research focuses on the use of a heterologously expressed bacterial FAS gene for synthesis 
of FAEEs in S.cerevisiae.  This FAS gene was isolated from the bacteria Brevibacterium 
ammoniagenes (4,5) and was previously shown in our laboratory to be active in S.cerevisiae (6).  
Unlike other FAS enzymes, this particular FAS  is unique because it does not produce fatty acids 
at varying chain lengths, it produces palmitic acid, C16, almost exclusively with no unsaturated 
fatty acids produced (5).  Having a uniform product will be significant for future biofuel 
applications, to allow for a consistent product.  In this project, the FAS is co-expressed with its 
phosphopantetheine transferase PPT1, as this domain is not a part of the larger complex.  The 
FAS is a very large enzyme, at 9.5 kb, which offers problems when cloning.  Further details on 
the specifics of this research project are explained below. 
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3.1.2.1 Overproduction of Fatty Acids and Biofuel Production 
Significant research has recently been accomplished producing biofuels from fatty acids.  One 
example is the n-butanol production from the reversal of β-oxidation (7) (Figure 3.4).  During the 
β-oxidation process fatty acids are broken down in the mitochondria to generate acetyl-CoA.  By 
expressing the following enzymes the actual β-oxidation process is reversed: the thiolase FadA, 
then a hydroxyacyl-CoA dehydrogenase FadB, also the enoyl-CoA hydratase FadB, and finally 
an enoyl-CoA reductase YdiO.  The reversal will actually build up fatty acids, which can be used 
to produce butanol products after the over-expression of an alcohol dehydrogenase and an acyl-
CoA thioesterase.  As a proof of concept, the product of one reverse cycle, n-butanol, was 
produced at 12 g/L from this pathway.   
Another example of increased fatty acid production was from the Pfleger group (8) (Figure 3.5) .  
In this project, an E.coli strain that overproduces medium-chain length fatty acids via three basic 
modifications was accomplished.  These modifications included elimination of β-oxidation 
through gene knockout of fadD, overexpression of the four subunits of acetyl-CoA carboxylase, 
and the expression of a plant acyl-acyl carrier protein (ACP) thioesterase.  The thioesterase was 
the most significant component of this work, as this is the enzyme which pulled the fatty acid 
intermediates from the cyclical elongation process.  The excess fatty acids were extracted and 
then subsequently converted to alkanes.  A similar effort was also considered by Steen et al. 
where the thioesterase was expressed in the cytoplasm, instead of the periplasm, the truncated 
„TesA allowed for increased production of free fatty acids (9). 
In a final example, Kalscheuer et al. overexpressed an unspecific acyltransferase from 
Acinetobacter baylyi (1), which produced microdiesel in E.coli.  This unspecific acyltransferase    
catalyzes the esterification of a fatty acyl-CoA and a fatty alcohol to produce the FAEE.  This 
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method was only possible by overexpression of a pyruvate decarboxylase and an alcohol 
dehydrogenase.  Thus, the ethanol formation from the pyruvate decarboxylase and an alcohol 
dehydrogenase was subsequently esterified by the acyltransferase with the acyl moieties of 
coenzyme A thioesters of fatty acids to produce FAEEs.  1.25 g/L of FAEEs were produced after 
70 hours using this method (1).  Further information about the acyltransferase is available in the 
next section. 
 
3.1.3 Wax Ester Synthase/acyl-coenzyme A:Diacylglycerol Acyltransferase 
The wax ester synthase/acyl-coenzyme A:diacylglycerol acyltransferase (WSDGAT) enzyme is 
a relatively new family of acyltransferase enzymes.  This enzyme exhibits bifunctional catalytic 
activities (10,11) (Figure 3.6) and is responsible for catalyzing the esterification of a fatty acyl-
CoA and a fatty alcohol.  This class of enzymes is instrumental in energy storage and lipid 
accumulation.  It was first discovered in Acinetobacter baylyi (1) and a few other homologs have 
been cloned (12,13).  Sequence identity between the homologous enzymes is about 20%, which 
is considered to be low.  However, the enzymes share the assumed active site motif 
(HHXXXDG) (14).  Recent studies have investigated the composition of the natural wax esters 
or TAGs produced by these enzymes when they are heterologously expressed in E.coli to 
determine the substrate specificities of the enzymes (14).  The lipid profiles produced indicate a 
large variation in the types of neutral lipids they accumulate, thus confirming the promiscuity of 
the enzyme.  A second study noted that the wax ester synthases naturally accept acyl groups with 
carbon chain lengths of C16 or C18 and linear alcohols with carbon chain lengths ranging from C12 
to C20 (15).  In follow-up work, a sequenced-based homolog study identified residues affecting 
the fatty alcohol selectivity (16).  In this work, the mutation in the protein Ma1 from 
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Marinobacter aquaeolei VT8, A360I, was originally investigated to block the putative substrate 
pocket from large fatty acids.  While this mutation did not affect large fatty acid binding, it was 
found to improve the rate of reaction with smaller fatty acids such as nonanol.  The mutant 
exhibited an improvement in specific activity that was 8-fold greater than the wild-type.  Further 
mutations to the site did not block large fatty acid binding.  This result was also found in the 
previously characterized WSDGAT from A. baylyi.  As the crystal structure is not yet available 
for this enzyme, further discussion about the structure-function relationship of this mutation 
cannot occur. 
The most interesting of these recent studies comes from the functional expression and 
characterization of five wax ester synthases in S.cerevisiae and their utility for biodiesel 
production (15).  In this study, five WSDGATs were examined in crude cell extracts of 
S.cerevisiae.  The wax ester synthases (WSs) were from Acinetobacter baylyi, Marinobacter 
hydrocarbonoclasticus, Rhodococcus opacus, Mus musculus, and Psychrobacter articus.  It was 
shown that the WS2 from M. hydrocarbonoclasticus was the most efficient at biodiesel 
production in S.cerevisiae.  This enzyme produced 6.3 mg/L of FAEEs.  No FAEEs were 
detected in the control strain.  In this study, the acetyl coenzyme A carboxylase was also over-
expressed, which resulted in a 30% increase in biodiesel production across all strains.  Based on 
the recent success of the study, the WS2 was introduced into the experiments of this thesis. 
 
3.1.4 Project Goal  
For this project, it was desired to overproduce fatty acids via a bacterial FAS and then have the 
fatty acids subsequently converted to FAEEs by a WSDGAT in S.cerevisiae (Figure 3.7).  A 
major limitation in fatty acid overproduction is the complex endogenous regulatory network that 
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limits fatty acid synthesis. Therefore, we sought to overproduce fatty acids through the 
heterologous expression of a bacterial FAS: it is expected that the bacterial FAS will not be 
subjected to the endogenous regulation of fatty acid synthesis in yeast.  Thus, the production of 
fatty acids will not be limited by the mechanistic regulation.  Heterologous expression of FAS 
for overproduction of fatty acids has not previously been accomplished; this is the main novelty 
and significance of this project.  The bacterial FAS we chose to overexpress is the 
Brevibacterium ammoniagenes FAS-B because this enzyme exclusively produces a single-length 
fatty acid: C16. Also, the FAS-B was previously proven to have functional expression in 
S.cerevisiae (6).  The WSDGATs were used based on their relatively high activity shown in the 
literature (13,15,17).  The chosen chassis, S.cerevisiae, is significant for its endogenous 
production of ethanol. Other studies which produced FAEEs in E.coli required the introduction 
of the ethanol pathway (1,9).  Shi et al. recently illustrated the advantage of using the 
endogenous ethanol pathway in S.cerevisiae (15).  Yeast is also more desirable than E.coli as an 
industrial host due to its robustness, phage resistance, and ability to grow at low pH, which 
reduces the risk of contamination. 
 
3.2 Results  
3.2.1 Plasmid Construction 
Three WSDGAT genes have been cloned, including WS2 [GenBank Accession No: 
ABO21021.1], mhWSDGAT [GenBank Accession No: ABO21020.1], and  abWSDGAT [NCBI 
Reference Sequence: YP_045555.1].  The WS2 gene was codon optimized and synthesized by 
DNA 2.0 (Menlo Park, CA), while the other two WSDGAT genes from Marinobacter 
hydrocarbonoclasticus and Acinetobacter baylyi were cloned from the cDNA of the organisms.  
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The fas-B and PPT1 were cloned from pGM44 (4).  For ease of construction, the project was 
apportioned into two separate modules: module 1 involved expression of  fas-B and PPT1 while 
module 2 involved expression of the WSDGAT genes.  In module 1, the plasmids included both 
a high and low copy version of: pRS424-TPIp-FAS-TPIt-TEFp-PPT1-TEFt.  In module 2, there 
were three plasmids, in high and low copy versions of: pRS425-PYKp-mhWSDGAT-PYKt, 
pRS425-PYKp-abWSDGAT-PYKt, pRS425-PYKp-WS2WSDGAT-PYKt (Figure 3.8).  The 
plasmids were first assembled into the low copy plasmids before being transferred into the high 
copy plasmid as a single gene cassette.  The high copy plasmids were used for all further 
characterization.  Construction of these plasmids was confirmed via PCR fragments, DNA 
restriction digests, and sequencing.  By separating the pathway into modules with individual 
expression of the enzymes, separate expression, and activity assays could be performed.  
However, the modules are currently being combined for biodiesel production.  A fourth gene was 
included in the full pathway, an acyl-CoA ligase, to convert the fatty acids to fatty acyl-CoA.  
The full biodiesel pathway and combination of the modules will result in three plasmids.  For 
simplicity, the promoter/terminator names are not included here, but are the same as in the 
module stated above: pRS424- FAS-PPT1-FAA1-mh WSDGAT, the second plasmid is FAS-
PPT1-FAA1-ab WSDGAT, and the third plasmids is FAS-PPT1-FAA1-WS2 WSDGAT (Figure 
3.9).   
 
3.2.2 Expression Studies 
The FAS-B and WSDGATs were tested for expression in both E.coli and S.cerevisiae through 
SDS-PAGE experiments and Western blot analysis.  SDS-PAGE experiments in E.coli for the 
abWSDGAT and mhWSDGAT showed positive expression.  A clear band at about 55 kDa was 
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shown for ab- and mh- WSDGAT in E.coli cultures (Figure 3.10).  The FAS-B expression in 
E.coli was not as easily identified, even after efforts to concentrate the sample significantly, the 
FAS was barely visible on the SDS-PAGE gel.  The figure is not shown as the band was so faint, 
it was not visible in a photographic image. 
The Western blots analysis for expression in S.cerevisiae was not successful.  In these 
experiments, after efforts to significantly concentrate the sample, a faint band for the 
mhWSDGAT could be seen.  The figure is not shown as the band was so faint, it was barely 
visible in a photographic image.  However no bands for the abWSDGAT or the FAS-B were 
visible.  The WS2 WSDGAT was not tested because at this time, we had not yet identified the 
advantage of the WS2 enzyme. 
 
3.2.3 qPCR  
To further test the expression of the WSDGAT enzymes and the FAS-B, a more sensitive 
method was used.  Quantitative-PCR was used to detect minute amounts of the mRNA from 
these enzymes.  The FAS-B and PPT1 were tested and shown to have significant level of mRNA 
compared to the negative control.  The abWSDGAT was also tested, and shown to have 
significant levels of mRNA compared to the negative control.  The mhWSDGAT was not tested 
because construction of the plasmid was not completed at the time.  The WS2 was not subjected 
to the qPCR at this time because it had not yet been identified for use.  All expression levels are 
normalized to the housekeeping gene asparagine-linked glycosylation 9 gene (alg9) expression 
to determine expression levels (Figure 3.11). 
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3.2.4 WSDGAT Assay 
The activity assay for the WSDGAT measured the fatty alcohol and fatty acyl-CoA esterification 
catalyzed by the WSDGAT enzyme.  This was done by monitoring the reaction of 5,5'-dithio-
bis-(2)-nitrobenzoic acid (DTNB) with the free sulfhydryl-CoA released during the esterification 
reaction.  The reaction of DTNB with sulfhydryl produces NTB2-, a yellow-colored compound 
which can be quantified at a wavelength of 412 nm (Figure 3.12).  This approach has been used 
by other research groups (13,14,18).  It was found that the order in which substrate and enzymes 
are added in this assay is very important.  For this particular work, the activity in the crude lysate 
of S.cerevisiae was being tested and ethanol was used as the co-substrate.  This was a very noisy 
assay, wherein the negative control was very high.  However, we have shown that both the mh 
and ab WSDGAT have activity significantly higher than the negative control in S.cerevisiae.  At 
this time, the WS2 was not tested; however future work will repeat these assays with the WS2.  
One unit is defined as a µmole/min of NTB produced, which is stoichiometrically equivalent to a 
µmole/min of thiol being released.  The activity was normalized by the total concentration of 
protein in the lysate.  The background was subtracted from the final assay measurements.  The 
abWSDGAT was shown to have the lowest activity at 0.02 U/mg and the mH WSDGAT had a 
higher activity at 0.07 U/mg.  The purified mhWSDGAT was also used as a positive control 
(Figure 3.13). 
 
3.2.5 FAS-B Activity Assay 
3.2.5.1 Fatty Acid Extraction Method 
Initial work had to consider which fatty acid extraction method to use.  Two methods were 
available: the Dryer method (chloroform: methanol) or the ethyl-acetate method.  The same 
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sample was divided and subjected to both methods, in duplicate.  It was shown that the Dryer 
method was less noisy and more specific for the extraction of lipids and fatty acids.  The ethyl-
acetate method produced multiple peaks and other un-wanted products in the GC-chromatogram 
(Figure 3.14). 
 
3.2.5.2 Detection of Fatty Acids from FAS 
The production of palmitic acid (C16) was tested in S.cerevisiae in YPD cultures grown for 72 
hours.  No palmitic acid was detected at all when cultures were grown in synthetic-dropout 
media, thus rich media was used in all characterizations.  The cultures were subjected to fatty 
acid extraction through the Dryer method.  Detection of the fatty acids was shown to not be 
reproducible and in very small quantities (Figure 3.15). 
 
3.3 Discussions 
3.3.1 Cloning  
The mhWSDGAT and abWSDGAT genes were successfully cloned from the M. 
hydrocarbonoclasticus DSMZ 8798 and A. baylyi DSMZ 14959, respectively.  However, after 
we cloned these genes, Shi et al. discovered a second WS enzyme from M. 
hydrocarbonoclasticus which had significant activity.  Thus the WS2 gene was codon optimized 
and synthesized by DNA 2.0. 
 
3.3.2 WSDGAT Activity 
The assay to detect the WSDGAT activity was based the liberation of the sulfhydryl-CoA from 
the fatty alcohol and fatty acyl-CoA esterification.  The reagent DTNB was used to react with the 
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released sulfhydryl-CoA.  However, DTNB will react with any sulfhydryl group, thus this assay 
will have a very large background noise, because there are many different sulfhydryl groups in 
the cell crude lysate that could react with the DTNB.  It was interesting to find that the order of 
substrates added was shown to have significant effects on the overall result.  The enzyme should 
be added last.  This discovery was also recently published by Barney and coworkers (14).  In this 
work, Barney suggests that this could indicate a mechanism of allosteric control of protein 
activity based on substrate levels within the cell. 
Though the expression studies of the WSDGAT in S.cerevisiae did not yield positive results, the 
activity assay proved that the gene was functionally expressed.  The activity may be low, but it is 
active.  This functional expression was also recently demonstrated by Shi et al. (15).  In this 
work, the WS2 and the abWSDGAT were functionally expressed in S.cerevisiae for biodiesel 
production.  It was found that the WS2 produced the highest biodiesel titer.  The mhWSDGAT 
was not tested in the study by Shi.  The future work of the WSDGAT activity will include testing 
all three enzymes, WS2, mh-, ab-WSDGAT.   
 
3.3.3 FAS-B Activity 
The irreproducibility of the palmitic acid production was initially troublesome.  Having 
reproducible results is very important and had become a significant part of this project.  
However, after careful analysis and discussions with the new post-doctorate in the laboratory 
whom has had greater experience with fatty acids, this irreproducibility is now accepted as 
standard operating procedure when working with fatty acids.  This type of system is inherently 
error-prone and making it more reproducible is futile.  Therefore, future work will need to focus 
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on methods which over-produce fatty acids enough to make the error-margin insignificant 
compared to the amount of fatty acids being produced. 
 
Not being able to detect excess C16 was troublesome.  There are many reasons why this could 
have occurred.  It is possible that the incubation time was too long.  The current incubation time 
was at 70 hours, however it is possible that at this time, all of the nutrients had been utilized in 
the media and the cells had reverted to using the C16 energy storage, thus degrading the fatty 
acids.  It is also possible that the excess fatty acids were degraded by the endogenous system due 
to the toxicity of excess fatty acids.   
 
3.4 Conclusions and Future Work 
Future work for this product will combine the FAS-B/PPT1 and WSDGAT modules to look for 
FAEE production.  We are choosing to try this new strategy because it is expected that any 
excess fatty acids produced by the heterologously expressed FAS are being degraded.  Therefore, 
it is hypothesized that incorporating a driving force for the conversion of fatty acids to FAEE, it 
is more likely that the excess fatty acids can be quantified and will not be degraded.  The FAEE 
is not endogenously produced by the cell, so small quantities of the FAEE being produced will 
not be lost in the error-margin of the fatty acid production.  Additionally, the FAEE cannot be 
utilized by the cell and will not be degraded.  This new strategy was also partially instigated by 
the recent discovery of functional WSDGAT expression in S.cerevisiae (15).  This project 
successfully expressed the WSDGATs in S.cerevisiae and detected FAEEs.  Therefore, this 
strategy is a better platform: detect the FAEEs and optimize production.  We must also keep in 
mind the error-margin that is inherent with working in fatty acids.  Therefore, future work will 
77 
 
need to focus on methods which over-produce fatty acids enough to make the error-margin 
insignificant compared to the amount of fatty acids being produced.  The design of experiments 
(DOE) for this new approach will involve identifying FAEEs from the single expression of the 
WSDGATs in S.cerevisiae, as was previously shown by Shi et al. (15).  The DOE will also look 
at the combined expression of the FAS-B+WSDGAT to identify if the FAEE production is 
increased with the FAS expression. 
At this time, the WS2 was not tested for any activity; future work will include testing the WS2 
for activity towards ethanol, using the liberated Co-A mechanism for quantification.  We also 
expect to repeat the crude enzyme lysate testing of the mh- and ab- WSDGAT for a complete 
analysis of all three enzymes comparatively.  The WS2 is also being included in the FAEE 
testing. 
 
3.5 Materials and Methods 
3.5.1 Cloning from cDNA 
The bacteria M. hydrocarbonoclasticus and A. baylyi were grown in Luria Broth (LB) media.  
The total RNA was isolated from fresh samples using the Qiagen RNeasy Mini Kit (Qiagen, 
Valencia, CA) following manufacturer‟s instructions.  Isolated RNA samples were cleaned using 
TURBO DNA-free Kit (AMBION INC, Austin, TX) and then reverse transcribed into cDNA 
using the Transcriptor First Strand cDNA Synthesis kit (Roche, Mannheim, Germany) with the 
oligo-dT primer following the manufacturer‟s instructions.  Gene specific primers were used for 
the qPCR analysis from the cDNA (Table 3.1). 
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3.5.2 Yeast Plasmid Construction 
The DNA Assembler method was used for all yeast plasmid construction (19).  Yeast expression 
plasmids were constructed in a two module system: module 1 involved expression of FAS-B and 
PPT1 while module 2 involved expression of the WSDGATs.  In module 1, the plasmids were 
both a high and low copy version of: pRS424-TPIp-FAS-TPIt-TEFp-PPT1-TEFt.  In module 2, 
there were three plasmids, in high and low copy versions of: pRS425-PYKp-mhWSDGAT-
PYKt, pRS425-PYKp-abWSDGAT-PYKt, pRS425-PYKp-WS2WSDGAT-PYKt (Figure 3.8).  
The FAS-B and PPT1 were amplified from the pGM44 plasmid (4) using gene specific primers 
from Table 3.1.  The WS2 gene was synthesized by DNA 2.0, while the other two WSDGATs 
from M. hydrocarbonoclasticus and A. baylyi were cloned from the cDNA.  A final yeast 
plasmid system is currently being constructed, combining both module 1 and module 2 into a 
single plasmid, shown in Figure 3.9 using the DNA Assembler method.   
 
3.5.3 E.coli Plasmid Construction 
The WSDGAT genes were cloned into a pET-28a vector for protein purification.  The genes 
were amplified from the pRS416- WSDGAT plasmid for the respective WSDGAT.  The primers 
for the construction are shown in Table 3.1.  The primers included unique restriction digestion 
sites NdeI and XhoI for ligation into pET-28a. As mhWSDGAT has a NdeI site located within 
the gene, the restriction digest NcoI had to be used.  This primer was very long to incorporate the 
histidine tag and was used to amplify the mhWSDGAT gene for ligation using NcoI and XhoI.  
Standard ligation with New England Biolabs (Ipswich, MA) ligase was used, following the 
manufacturer‟s protocol.  The ligation reaction was transformed through electroporation into 
79 
 
DH5α E.coli cells from the Cell Media Facility (University of Illinois Urbana-Champaign, 
Urbana, IL). 
 
3.5.4 SDS-PAGE 
E.coli BL21 cells were used to test expression through SDS-PAGE gels.  The cells were 
inoculated to an OD of 0.2 and grown for 2 hours at 37 °C.  The cells were then induced with 
0.7mM  IPTG  and grown for 6 hours at 30 °C.  A sample was taken, washed with sterile water, 
then concentrated to either 10x or 100x for a final resuspension volume of 100 µL of 100 mg/mL 
lysozyme (Sigma Aldrich, St.  Louis MO) in 100 mM potassium phosphate buffer pH 7 and then 
frozen at -80°C.  The sample was then subjected to two rounds of freeze-thaw cycles before 
being pelleted. Standard SDS-PAGE gel protocol was followed.   
 
3.5.5 Western Blotting 
S.cerevisiae cells were inoculated at 0.2 OD and grown in 50 mL rich media in baffled flasks 
overnight at 30 °C.  Cells were washed twice with water and concentrated either 10x or 100x 
with Yeast Breaking Buffer (MP Biomedical, Solon, OH).  1 mL of the culture was aliquoted out 
to Yeast Fast Prep Matrix C columns (MP Biomedical).  The cells were lysed using the Fast 
Prep, with 40 second intervals of shaking at a setting shaking speed of 6.0 M/s.  This was 
repeated seven times, with five minutes on ice in between each interval.  The sample was then 
spun down to separate the lysate soluble and insoluble fractions.  The protein concentration was 
determined via the Bradford Assay (Thermo Fisher Scientific, Rockford IL).  A standard 
Western blot protocol was followed. 
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3.5.6 Protein Purification 
Proteins with a histidine-tag were purified via a Talon Co2+ resin (Clontech).  E.coli BL21 cells 
were used to express the protein for purification.  To express the cells, 600 mL of LB media + 
100 mg/ml kanamycin was used and an overnight culture was used to inoculate to an OD of 0.2.  
The culture was allowed to grow to an OD of 0.8 at 37 °C and 250 rpm, before being induced 
with 0.7mM IPTG.  The temperature was then reduced to 30 °C and incubated for 6 hours.  The 
cells were then harvested washed twice with sterile water, pelleted, and stored at -80 °C until 
use.  The thawed pellets were then lysed using an Avestine homogenizer (Ottawa Canada) in 100 
mg/mL lysozyme in 100 mM potassium phosphate buffer pH7.  The sample was then purified 
through standard manufacturer‟s protein purification protocols for a Talon Co2+ resin column.  
The purified protein was stored at -80 °C until use.  The enzyme concentration was tested by the 
Bradford Assay following the manufacturer‟s protocol. 
 
3.5.7 WSDGAT Activity Assay 
The WSDGAT activity was tested using purified mhWSDGAT and also crude lysate of ab- and 
mh- WSDGAT in S.cerevisiae.  For the crude lysate, the cells were inoculated at 0.2 OD and 
grown in 50 mL of the appropriate nutrient drop-out media in baffled flasks overnight at 30 °C.  
Cells were washed twice with water and concentrated 10x with Yeast Breaking Buffer (MP 
Biomedical, Solon, OH).  1 mL of the culture was aliquoted out to Yeast Fast Prep Matrix C 
columns (MP Biomedical).  The cells were lysed using the Fast Prep, with 40 second intervals of 
shaking at a speed of 6.0 M/s.  This was repeated seven times, with five minutes on ice in 
between each interval.  The sample was then spun down to separate the lysate soluble and 
insoluble fractions.  The protein concentration was determined via the Bradford Assay following 
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manufacturer‟s protocol.  Ellman‟s reagent was used to test the sulfhydryl groups (20).  The 
following conditions were used for the assay buffer: 100 mM potassium phosphate buffer pH 8, 
1mM EDTA with 0.1% Tergitol NP-11 detergent, 100 mM MgCl2, 10 mM DNTB, 2500 M 
palmitoyl-CoA, and 2500 M ethanol.  1 mL was then transferred to UV cuvettes and blanked 
on a Cary 300 UV-Visible spectrophotometer (Agilent Technologies, Santa Clara, CA).  10 L 
of the crude lysate was added and the absorbance was monitored at 412 nm. 
 
3.5.8 Fatty Acid Extraction  
3.5.8.1 Ethyl-Acetate 
The strains to be tested were grown in 5 mL YPD media overnight and then transferred to a 15-
mL glass test tube.  50 µM C19 dissolved in ethanol was added as an internal standard.  5 mL of 
ethyl acetate was added using a glass pipette and 500 µL of 6N HCl.  The sample was then 
vortexed for 10 seconds and agitated at 30 °C at 250 rpm for 30 minutes.  The sample was then 
allowed to phase separate and the top phase was aspirated off and transferred to a glass 
scintillation vial.  This organic phase was allowed to dry overnight in the fume hood.  Then 500 
µL of a 2:1 methanol: toluene solution was added using a glass pipette.  100 µL of 2N TMS-
diazomethane was added.  The mixture was shaken to mix and then allowed to derivatize for 1 
hour at 37°C.  The remaining sample was then transferred to a glass GC tube for analysis.   
 
3.5.8.2 Dryer Method 
The strains to be tested were grown in 5 mL YPD media overnight and transferred to a 15-mL 
glass test tube.  50 µM C19 dissolved in ethanol was added as an internal standard.  5 mL of a 2:1 
solution of chloroform: methanol was added with a glass pipette and vortexed for 10 seconds and 
82 
 
agitated at 30 °C at 250 rpm for 30 minutes.  The sample was then allowed to phase separate.  
The top phase was aspirated off and the bottom layer was transferred to the glass scintillation 
vial.  The top layer was recovered for further extraction as needed.  The bottom layer which had 
been transferred to the scintillation vial was then allowed to dry overnight in the fume hood.  
Then 500 µL of a 2:1 methanol: toluene solution was added using a glass pipette.  100 µL of 2N 
TMS-diazomethane was added.  The mixture was shaken to mix and then allowed to derivatize 
for 1 hour at 37 °C.  The remaining sample was then transferred to a glass GC tube for analysis. 
 
3.5.9 GC-MS Analysis  
The fatty acids were separated and quantified through a GC-MS-QP 2010 Plus (Shimadzu, 
Kyoto Japan).  The separation was performed by a DB-WAX GC column with the following 
dimensions: 30mm x 0.25 mm internal diameter, 0.25 µm film thickness, from Agilent 
Technologies (Santa Clara, CA).  A 1 µL portion was injected via split less injection at 250 °C at 
an initial pressure of 98 kPA and a total flow of 14.1 mL/min helium carrier gas.  The 
chromatograph separation initially occurred at a temperature of 140 °C for five minutes and then 
increased at a rate of 5 °C per minute to 250 °C and then held for three minutes.  The mass 
transfer line and ion source were at 250 and 200 °C respectively.  The fatty acids were detected 
with an electron ionization method in scan mode from 30 to 150 m/z.  The identification was 
achieved by comparison of retentions times and mass spectrum. 
 
3.5.10 qPCR Analysis 
Samples of cultures grown to mid-late exponential phase were used to compare relative mRNA 
expression levels of enzymes via quantitative PCR (qPCR).  The total RNA was isolated from 
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fresh samples using the Qiagen RNeasy Mini Kit (Qiagen, Valencia, CA) following 
manufacturer‟s instructions.  Isolated RNA samples were cleaned using TURBO DNA-free Kit 
(AMBION INC, Austin, TX) and then reverse transcribed into cDNA using the Transcriptor 
First Strand cDNA Synthesis kit (Roche, Mannheim, Germany) with the oligo-dT primer 
following the manufacturer‟s instructions.  The qPCR was performed with LightCycler 480 
SYBR Green Master reagents (Roche) using the Roche Light Cycler® 480 System (Roche, 
Indianapolis, IN) using gene specific primers (Table 3.1).  The relative abundance of the mRNA 
levels for the target genes was normalized to the asparagine-linked glycosylation 9 gene (alg9) 
expression to determine expression levels. 
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3.7 Tables 
Table 3.1: The primers used in this study 
 
  
FAS Primers
TPI F 5'- GACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGATATATCTAGGAACCCATCA -3'
TPI R 5'- AAACACATACATAAACTAAAAATGACTATTGGCATCTCTAACCACCGCCTGGTGAACCG -3'
FAS  F 5'- TAAATCTATAACTACAAAAAACACATACATAAACTAAAAATGACTATTGGCATCTCTAAC -3'
FAS R 5'- CTACGGCAAGCCACCAGTGAGATTAATATAATTATATAAAAATATTATCTTCTTTTCTT -3'
TPIt F 5'- CAAGGCGTGGTCGCAAGCGATCTACGGCAAGCCACCAGTGAGATTAATATAATTATATAA -3'
TPIt R 5'- AAATTTCAACTGTTATATAATAGCTTCAAAATGTTTCTACTCCTTTTTTACTCTTCCAG -3'
TEFP 5'- GTTGAGAAGATGTTCTTATCCAAATTTCAACTGTTATATAATAGCTTCAAAATGTTTC -3'
TEF t 5'- CTAAGTTTTAATTACAAAATGCTCGACAACCGTGAAGCGATGACCGTGGGTGTGGACTTG -3'
PPT1 5'- GAAAGAAAGCATAGCAATCTAATCTAAGTTTTAATTACAAAATGCTCGACAACCGTGAAG -3'
PPT1 R 5'- CTGCGGTACCAGCGGTAAGGAGATTGATAAGACTTTTCTAGTTGCATATCTTTTATAT -3'
TEF t 5'- CGCCACCGCGCAGTGCCTGCTGCGGTACCAGCGGTAAGGAGATTGATAAGACTTTTC -3'
TEF t R 5'- CTTTGATCGGCGCTATACGCGTCCACCGCGGTGGAGCTCCAGCTTTTGTTCCCTTTAG -3'
WSDGAT Primers
PGKp F 5'- CAAATACTTTGATCGGCGCTATACGCACAGATATTATAACATCTGCACAATAGGCATTTG -3'
PGKp R - to ab 5'- CAAGGAAGTAATTATCTACTTTTTACAACAAATATAAAACAATGCGCCCATTACATCCG -3'
ab F 5'- CAAGGAAGTAATTATCTACTTTTTACAACAAATATAAAACAATGCATCATCATCATCATC -3'
ab r 5'- GTAATTGCAAAGCAGGAAGATATTAAAACAGCCAATTAAATTGAATTGAATTGAAATCG -3'
PGK p R to mh 5'- TACAACAAATATAAAACAATGACGCCCCTGAATCCCACTGACCAGCTCTTTCTCTGGC -3'
PGKp  Rto WS2 5'- TACAACAAATATAAAACA ATGAAGAGATTAGGTACTCTAGACGCTAGTTGGCTTGCAG -3'
mH F 5'- CAAGGAAGTAATTATCTACTTTTTACAACAAATATAAAACAATGACGCCCCTGAATCCC -3'
mH R 5'- GAGCTCAACGCCGGTCTGTAAATTGAATTGAATTGAAATCGATAGATCAATTTTTTTC -3'
WS2 F 5'- GGAAGTAATTATCTACTTTTTACAACAAATATAAAACAATGAAGAGATTAGGTACTCTAG -3'
WS2 R 5'- GCGTGCCCGTACTAGAAAGTAAATTGAATTGAATTGAAATCGATAGATCAATTTTTTTC -3'
PGKt F to ab 5'- GTAATTGCAAAGCAGGAAGATATTAAAACAGCCAATTAAATTGAATTGAATTGAAATC -3'
PGKt F to mh 5'- CAGGGTCTGGCAGAGCTGGAGCTCAACGCCGGTCTGTAAATTGAATTGAATTGAAATC -3'
PGKt F to WS2 5'- CTAATTCTGCCACCAAAGAAGCGTGCCCGTACTAGAAAGTAAATTGAATTGAATTGAAATC -3'
PGKt R 5'- GTATAGTGTATTCTTCCTGCCATGGCCAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCG -3'
WSDGAT pET 28 primers -3'
mh F 5'- GATATAC C A TGG GCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGACGCCCCTGAATCCCACTGACC -3'
mh R 5'- GAGCTCAACGCCGGTCTGTAACTCGAGCACCACCAC -3'
ab F 5'- CAGCCATATGACGCCCCTGAATCCCACTG -3'
ab R 5'- GATATTAAAACAGCCAATTAACTCGAGCACCACCACCACCACC -3'
WS2 F 5'- GGCAGCCATATGAAGAGATTAGGTACTC -3'
WS2 R 5'- CGTGCCCGTACTAGAAAGTAACTCGAGCACCACC -3'
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3.8 Figures 
 
Figure 3.1: General scheme of microbial production of FAEEs (15).   
 
 
Figure 3.2: Mechanism of fatty acid biosynthesis (2).   
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Figure 3.3: Schematic representation of the globular multi-functional enzyme complex FAS-B. 
 
Figure 3.4: Reversal of the β-oxidation process.  In this diagram, the enzymes are 1) 3-ketoacyl-
CoA synthase; 2) 3-ketoacyl-CoA reductase; 3) 3-hydroxyacyl-CoA dehydratase 4) trans-2-
enoyl-CoA reductase. 
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Figure 3.5: Metabolic engineering strategies used to overproduce fatty acids (8).  
Overexpression of the ACC allowed for the first committed step of the fatty acid pathway, 
pushing the flux towards fatty acids.  Overexpression of the acyl-ACP thioesterase pulled the 
intermediates out of the cyclical fatty acid pathway.  Also, knocking out fadD eliminated the 
breakdown of fatty acids in the β-oxidation pathway. 
 
 
Figure 3.6: The WSDGAT is a bifunctional enzyme, with two reaction capabilities: wax ester 
synthase and AcylA:diacylglycerol transferase.  We are interested in the wax synthase (WS) 
reaction (17).   
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Figure 3.7: The general scheme for this research project. The heterologous expression of a 
bacterial Type I FAS is expected to overproduce the fatty acids because it will not be limited by 
endogenous regulation mechanisms. The overexpressed C16 will then be converted to FAEE by 
WSDGAT. 
 
Figure 3.8: The initial plasmids created with individual enzymes WSDGAT and the FAS-B for 
activity analysis.   
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Figure 3.9: The final full biodiesel pathway which will consist of the FAS-B and the WSDGAT 
enzymes to produce FAEEs.   
 
 
 
Figure 3.10: SDS-PAGE analysis of the mhWSDGAT and abWSDGAT enzymes expressed in 
E.coli.  Lane 1: Ladder, Lane 2-3: Negative controls, Lane 4-6:  mhWSDGAT Lane 7-9: 
abWSDGAT. 
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Figure 3.11: qPCR analysis of the FAS-B gene, the PPT1 gene, and the abWSDGAT gene. 
 
 
 
 
Figure 3.12: Scheme of the Ellman‟s reaction.  DTNB reacts with the sulfuryl group to create a 
measureable yellow color.  This is used in WSDGAT activity analysis to detect the release of the 
sulfuryl-CoA. 
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Figure 3.13: The data of the WSDGAT Ellman‟s reagent reaction.  The negative was very high, 
but has been subtracted.  The abWSDGAT and mhWSDGAT are both active.   
 
 
Figure 3.14: The GC chromatograms showing the two methods to extract fatty acids.  The top 
method is the Dryer method (chloroform:methanol) and the second chromatogram is the ethyl 
acetate method.  It is shown that the Dryer method is less noisy. 
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Figure 3.15: Detection of the C16 compound using GC-MS.  The negative control is the strain 
harboring an empty plasmid.  The FAS strain is expressing the fatty acid synthase FAS-B. 
 
 
 
